{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1742,"total_is_capped":false,"direct_labels_cover":5,"predictions_cover":1742,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"dd57b2333e5f","filters":{"topic":"Chronic Lymphocytic Leukemia Research"}},"results":[{"id":"W2120319857","doi":"10.1056/nejmoa1313984","title":"Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1500,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Chlorambucil; Obinutuzumab; Medicine; Rituximab; Internal medicine; Hazard ratio; Gastroenterology; Chronic lymphocytic leukemia; Oncology; Chemotherapy; Confidence interval; Leukemia; Cyclophosphamide; Lymphoma","authors":[{"name":"Valentin Goede","is_ca":false},{"name":"Kirsten Fischer","is_ca":false},{"name":"Raymonde Busch","is_ca":false},{"name":"Anja Engelke","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Clemens‐Martin Wendtner","is_ca":false},{"name":"Tatiana Chagorova","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Thomas Illmer","is_ca":false},{"name":"Stephen Opat","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Olga Samoylova","is_ca":false},{"name":"Karl‐Anton Kreuzer","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Hartmut Döhner","is_ca":false},{"name":"Anton W. Langerak","is_ca":false},{"name":"Matthias Ritgen","is_ca":false},{"name":"Michael Kneba","is_ca":false},{"name":"Elina Asikanius","is_ca":false},{"name":"Kathryn Humphrey","is_ca":false},{"name":"Michael Wenger","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01466347416376183,"gpt":0.2802251531773841,"spread":0.2655616790136222,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000911078,0.0001311138,0.0005124049,0.0002659549,0.00004313971,0.000009897079,0.00008264767,0.00005866252,0.0001136561],"category_scores_gemma":[0.001183836,0.00007819519,0.00002410113,0.0002156497,0.0002077559,0.00008914344,0.00002520484,0.0004265685,0.000003358472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002884485,"about_ca_system_score_gemma":0.00279418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004066583,"about_ca_topic_score_gemma":0.00008704099,"domain_scores_codex":[0.9983827,0.00007492852,0.0004567921,0.0001366421,0.0007008013,0.00024811],"domain_scores_gemma":[0.9985327,0.0004164864,0.0002067043,0.0001603756,0.0002840299,0.0003996655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0398563,0.0007390659,0.5455213,0.001578075,0.0009549637,0.003613056,0.01628406,0.001651024,0.00119655,0.003417417,0.03940926,0.3457789],"study_design_scores_gemma":[0.7910997,0.008686102,0.1660645,0.002875175,0.0002394424,0.002609646,0.000319245,0.005238844,0.00006562978,0.0006092513,0.0219992,0.0001932098],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948562,0.0002658843,0.0002642523,0.001628703,0.000145476,0.0001839161,0.000001624131,0.0000081404,0.002645833],"genre_scores_gemma":[0.9975011,0.00005688187,0.0003788289,0.000381218,0.001337747,0.000001082297,0.00001206977,0.000017361,0.0003137403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7512434,"threshold_uncertainty_score":0.7542829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326175431","doi":"10.1056/nejm200012143432402","title":"Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia","year":2000,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1004,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; McGill University","keywords":"Chlorambucil; Fludarabine; Chronic lymphocytic leukemia; Medicine; Internal medicine; Gastroenterology; Chemotherapy; Surgery; Leukemia; Cyclophosphamide","authors":[{"name":"Bercedis L. Peterson","is_ca":false},{"name":"Frederick R. Appelbaum","is_ca":false},{"name":"Jonathan E. Kolitz","is_ca":false},{"name":"Laurence Elias","is_ca":false},{"name":"Lois E. Shepherd","is_ca":true},{"name":"John Hines","is_ca":false},{"name":"Gregory A. Threatte","is_ca":false},{"name":"Richard A. Larson","is_ca":false},{"name":"Bruce D. Cheson","is_ca":false},{"name":"Charles A. Schiffer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02307593760935496,"gpt":0.2983763764993762,"spread":0.2753004388900212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001291724,0.0003642641,0.001228604,0.0002969655,0.0001069473,0.00002470118,0.0003438491,0.0001382747,0.002655348],"category_scores_gemma":[0.0002490241,0.0002105949,0.0001739373,0.0004270063,0.0003825467,0.0001656432,0.00001853684,0.0005002906,0.00004710094],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03570174,"about_ca_system_score_gemma":0.05768484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008053263,"about_ca_topic_score_gemma":0.00004147557,"domain_scores_codex":[0.9965845,0.00008539303,0.0009038359,0.0003255301,0.001467017,0.0006337683],"domain_scores_gemma":[0.9972683,0.0005748169,0.000323407,0.000494917,0.0005186091,0.0008199246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.08266214,0.0001730209,0.0002174304,0.0006301003,0.001209645,0.002638455,0.001843578,0.003656576,0.01084405,0.0000912226,0.06820558,0.8278282],"study_design_scores_gemma":[0.575955,0.01742519,0.0007973411,0.001597072,0.0003433891,0.0196416,0.00007424823,0.004892492,0.002562637,0.0003268408,0.3761301,0.0002541244],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9705575,0.01485602,0.0005074486,0.004373678,0.0003101913,0.001014025,0.000004314674,0.00005441843,0.008322422],"genre_scores_gemma":[0.9656609,0.007532567,0.001310481,0.002701091,0.01078342,0.00001829241,0.00005262011,0.0001014223,0.01183915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8275741,"threshold_uncertainty_score":0.9982564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2792666902","doi":"10.1056/nejmoa1713976","title":"Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":909,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Jewish General Hospital","funders":"F. Hoffmann-La Roche; AbbVie","keywords":"Venetoclax; Rituximab; Bendamustine; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Progression-free survival; Neutropenia; Leukemia; Gastroenterology; Immunology; Lymphoma; Chemotherapy","authors":[{"name":"John F. Seymour","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"James D’Rozario","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Carolyn Owen","is_ca":true},{"name":"John F. Gerecitano","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Rod Humerickhouse","is_ca":false},{"name":"Elizabeth A. Punnoose","is_ca":false},{"name":"Yan Li","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"Kathryn Humphrey","is_ca":false},{"name":"Mehrdad Mobasher","is_ca":false},{"name":"Arnon P. Kater","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03256968068832229,"gpt":0.3346197826151289,"spread":0.3020501019268066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002043694,0.0002980065,0.001091841,0.0007202798,0.0000657077,0.00001401644,0.000374109,0.00022706,0.002002484],"category_scores_gemma":[0.002388845,0.0001833201,0.0001186953,0.0007570903,0.0005672901,0.0001344943,0.00007156521,0.0008903082,0.0001321417],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1114828,"about_ca_system_score_gemma":0.1008596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001846669,"about_ca_topic_score_gemma":0.0007024489,"domain_scores_codex":[0.996312,0.000186007,0.001205185,0.000312467,0.001319619,0.0006647208],"domain_scores_gemma":[0.9971814,0.0006482477,0.0004308404,0.0005375281,0.0004559406,0.0007460522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0688731,0.0004214616,0.001543372,0.001331182,0.0008930662,0.03416755,0.009186972,0.0007114065,0.03507986,0.0003382762,0.1559497,0.691504],"study_design_scores_gemma":[0.717801,0.01842162,0.001311375,0.004036885,0.000271878,0.02114769,0.0002589937,0.01235506,0.002359828,0.0004063639,0.2213525,0.0002767023],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851534,0.006076059,0.0002027936,0.001835487,0.001321564,0.0003959399,0.000001302925,0.00003659967,0.004976823],"genre_scores_gemma":[0.9770455,0.001385184,0.000537781,0.0007633689,0.01594671,0.000003356137,0.000005141083,0.00005714914,0.004255769],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6912273,"threshold_uncertainty_score":0.9989098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2948436219","doi":"10.1056/nejmoa1815281","title":"Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"Venetoclax; Obinutuzumab; Medicine; Ibrutinib; Internal medicine; Oncology; Cancer research; Chronic lymphocytic leukemia; Leukemia","authors":[{"name":"Kirsten Fischer","is_ca":false},{"name":"Othman Al‐Sawaf","is_ca":false},{"name":"Jasmin Bahlo","is_ca":false},{"name":"Anna‐Maria Fink","is_ca":false},{"name":"Maneesh Tandon","is_ca":false},{"name":"Mark Dixon","is_ca":false},{"name":"Sandra Robrecht","is_ca":false},{"name":"Simon Warburton","is_ca":false},{"name":"Kathryn Humphrey","is_ca":false},{"name":"Olga Samoylova","is_ca":false},{"name":"A. M. Liberati","is_ca":false},{"name":"Javier Pinilla‐Ibarz","is_ca":false},{"name":"Stephen Opat","is_ca":false},{"name":"Liliya Sivcheva","is_ca":false},{"name":"Katell Le Dû","is_ca":false},{"name":"Laura Fogliatto","is_ca":false},{"name":"Carsten Utoft Niemann","is_ca":false},{"name":"Robert Weinkove","is_ca":false},{"name":"Sue Robinson","is_ca":true},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Sebastian Böettcher","is_ca":false},{"name":"Eugen Tausch","is_ca":false},{"name":"Rod Humerickhouse","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Clemens‐Martin Wendtner","is_ca":false},{"name":"Anton W. Langerak","is_ca":false},{"name":"Karl-Anton Kreuzer","is_ca":false},{"name":"Matthias Ritgen","is_ca":false},{"name":"Valentin Goede","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Mehrdad Mobasher","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009446074225422615,"gpt":0.2713665505737163,"spread":0.2619204763482937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004534493,0.00009933807,0.0003858301,0.0002014288,0.00002249882,0.000007150464,0.00004549238,0.0000460032,0.0001266131],"category_scores_gemma":[0.0002844133,0.00005989519,0.00001311378,0.0001382241,0.0001335854,0.0000783996,0.0000229548,0.0003147448,0.000002636991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00199569,"about_ca_system_score_gemma":0.00235783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000290956,"about_ca_topic_score_gemma":0.00003629606,"domain_scores_codex":[0.998903,0.00004110508,0.0003142961,0.0001171433,0.0004456042,0.000178873],"domain_scores_gemma":[0.9990492,0.0002746046,0.0001387775,0.0001105322,0.0001527275,0.0002741236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.006916377,0.00008183312,0.9465131,0.0004619482,0.00021129,0.0008464422,0.003251629,0.0001464462,0.0008275276,0.0003516377,0.003128237,0.03726356],"study_design_scores_gemma":[0.5194593,0.007028296,0.4587111,0.002544021,0.0001411203,0.002646723,0.0003588781,0.001463315,0.0000464601,0.000297033,0.00717483,0.0001288885],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971331,0.0006320113,0.00001255328,0.000675989,0.00009936753,0.0002317711,0.000001719065,0.000003916156,0.00120953],"genre_scores_gemma":[0.9986727,0.0001215706,0.0002082308,0.0002002961,0.0004650875,6.462957e-7,0.000007352952,0.00001241937,0.0003116541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5125429,"threshold_uncertainty_score":0.521866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016538158","doi":"10.1016/s0140-6736(20)30262-2","title":"Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":612,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Obinutuzumab; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Oncology; Leukemia; Cyclophosphamide; Chemotherapy","authors":[{"name":"Jeff P. Sharman","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Alan P Skarbnik","is_ca":false},{"name":"John M. Pagel","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Manali Kamdar","is_ca":false},{"name":"Talha Munir","is_ca":false},{"name":"Renata Walewska","is_ca":false},{"name":"Gillian Corbett","is_ca":false},{"name":"Laura Fogliatto","is_ca":false},{"name":"Yair Herishanu","is_ca":false},{"name":"Versha Banerji","is_ca":true},{"name":"Steven Coutré","is_ca":false},{"name":"George Follows","is_ca":false},{"name":"Patricia Walker","is_ca":false},{"name":"Karin Karlsson","is_ca":false},{"name":"Paolo Ghia","is_ca":false},{"name":"Ann Janssens","is_ca":false},{"name":"Florence Cymbalista","is_ca":false},{"name":"Jennifer A. Woyach","is_ca":false},{"name":"Gilles Salles","is_ca":false},{"name":"William G. Wierda","is_ca":false},{"name":"Raquel Izumi","is_ca":false},{"name":"Veerendra Munugalavadla","is_ca":false},{"name":"Priti Patel","is_ca":false},{"name":"Min Hui Wang","is_ca":false},{"name":"Sofia Wong","is_ca":false},{"name":"John C. Byrd","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1071913197879008,"gpt":0.3732692195852925,"spread":0.2660778997973917,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006653304,0.0006216026,0.002734075,0.0000781299,0.0003180192,0.0001592398,0.0004489995,0.0002212772,0.0002700468],"category_scores_gemma":[0.00136904,0.0003123292,0.0003237611,0.0003987885,0.0005688317,0.0001444425,0.0001147711,0.0002891118,0.00007855],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.05514649,"about_ca_system_score_gemma":0.04694984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005934138,"about_ca_topic_score_gemma":0.0001566782,"domain_scores_codex":[0.9963879,0.0002234296,0.0006771117,0.0008509788,0.0006975305,0.001163038],"domain_scores_gemma":[0.9957272,0.002226883,0.0003008849,0.0009895345,0.000205268,0.0005502166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9883257,0.00009084071,0.000006492772,0.0003645125,0.001545015,0.0002224872,0.001324752,0.0001612372,0.000625034,0.0001203737,0.003796209,0.003417405],"study_design_scores_gemma":[0.8222634,0.02364718,0.000001232651,0.0001515695,0.001429321,0.0002310813,0.0003451397,0.133111,0.001687558,0.0000186887,0.01678656,0.0003272425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774411,0.002043964,0.0002721774,0.002532489,0.0003120853,0.01532989,0.0001529336,0.0002671828,0.00164818],"genre_scores_gemma":[0.9879795,0.0009762169,0.0003940468,0.0009632415,0.004741546,0.002695345,0.0001098367,0.0001277472,0.002012555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1660622,"threshold_uncertainty_score":0.9999329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2902706178","doi":"10.1016/s1470-2045(18)30788-5","title":"Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":548,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Obinutuzumab; Ibrutinib; Chlorambucil; Medicine; Oncology; Internal medicine; Open label; Chronic lymphocytic leukemia; Venetoclax; Clinical trial; Leukemia; Chemotherapy; Cyclophosphamide","authors":[{"name":"Carol Moreno","is_ca":false},{"name":"Richard Greil","is_ca":false},{"name":"Fatih Demırkan","is_ca":false},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Bertrand Anz","is_ca":false},{"name":"Loree Larratt","is_ca":true},{"name":"Martin Šimkovič","is_ca":false},{"name":"Olga Samoilova","is_ca":false},{"name":"Jan Novák","is_ca":false},{"name":"Dina Ben‐Yehuda","is_ca":false},{"name":"Владимир Стругов","is_ca":false},{"name":"Devinder Gill","is_ca":false},{"name":"John G. Gribben","is_ca":false},{"name":"Emily Hsu","is_ca":false},{"name":"Chih‐Jian Lih","is_ca":false},{"name":"Cathy Zhou","is_ca":false},{"name":"Fong Clow","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Lori Styles","is_ca":false},{"name":"Ian W. Flinn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1690966730335881,"gpt":0.4438783636128727,"spread":0.2747816905792846,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001769183,0.0006341409,0.002968328,0.0002812369,0.0002691044,0.00006260517,0.001308901,0.0005341711,0.001030307],"category_scores_gemma":[0.001196867,0.0004364389,0.0002367173,0.0008621822,0.001541097,0.0001737264,0.0005896101,0.0004590179,0.0004142956],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.4727633,"about_ca_system_score_gemma":0.136178,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01336656,"about_ca_topic_score_gemma":0.009103237,"domain_scores_codex":[0.9944673,0.0007188064,0.001432905,0.0009766138,0.000732629,0.001671737],"domain_scores_gemma":[0.9941512,0.002655026,0.0006021512,0.001886903,0.0003308876,0.0003738612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9694715,0.001213591,0.000002389555,0.0003030658,0.0006738472,0.001063339,0.004450598,0.001169801,0.0006658924,0.0002399275,0.003035059,0.01771097],"study_design_scores_gemma":[0.7049532,0.03965658,0.000003436101,0.0001957912,0.0004312973,0.0002581363,0.0003088064,0.2162862,0.002762059,0.00005156614,0.03480954,0.0002834663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9748964,0.002162675,0.00004799807,0.0008890608,0.002007762,0.008868285,0.00008194969,0.0001074496,0.01093838],"genre_scores_gemma":[0.9893438,0.002786986,0.0003868274,0.0002749316,0.003709502,0.00119658,0.0001425422,0.0000967025,0.002062127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3365853,"threshold_uncertainty_score":0.9998829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2980937306","doi":"10.1038/s41375-019-0602-x","title":"Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute; TG Therapeutics; Astellas Pharma; BeiGene; Gilead Sciences; GlaxoSmithKline; Pharmacyclics; Genentech; Sunesis; Teva Pharmaceutical Industries; Celgene; AstraZeneca; Bristol-Myers Squibb","keywords":"Ibrutinib; Chlorambucil; Internal medicine; Neutropenia; Medicine; Chronic lymphocytic leukemia; IGHV@; Adverse effect; Hematology; Oncology; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","authors":[{"name":"Jan A. Burger","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Paolo Ghia","is_ca":false},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Osnat Bairey","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Steven Coutré","is_ca":false},{"name":"Stephen Devereux","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Helen O. McCarthy","is_ca":false},{"name":"David Simpson","is_ca":false},{"name":"Fritz Offner","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Sandra Dai","is_ca":false},{"name":"Indu Lal","is_ca":false},{"name":"James P. Dean","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0243989745233313,"gpt":0.3168264164823156,"spread":0.2924274419589843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002193253,0.0002091837,0.0005847287,0.00006154819,0.00005246209,0.00001113099,0.0001870846,0.00009138399,0.00008288454],"category_scores_gemma":[0.0001721415,0.0001284107,0.0001005842,0.0001788886,0.0001491461,0.00004853412,0.00009929555,0.0001155685,0.000009113764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003739966,"about_ca_system_score_gemma":0.001444819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001433717,"about_ca_topic_score_gemma":0.0003807659,"domain_scores_codex":[0.9982374,0.0000579463,0.0004463586,0.0004089837,0.0005398833,0.0003094834],"domain_scores_gemma":[0.9976087,0.001106641,0.0001891281,0.0007978646,0.0001754296,0.0001222436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05682265,0.004078681,0.8651747,0.0003437853,0.001445297,0.00006136527,0.005701291,0.00005485595,0.0003283714,0.00001816805,0.0004389305,0.06553192],"study_design_scores_gemma":[0.3759435,0.01414117,0.60457,0.0004189527,0.0005201485,0.000004937047,0.000257434,0.001004804,0.001452912,0.000007923651,0.001504555,0.0001737022],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951472,0.0002307342,0.00002207595,0.00009081201,0.0000965056,0.00407856,0.0002379442,0.00001910553,0.0000770847],"genre_scores_gemma":[0.9988234,0.00009644711,0.0001266333,0.00004111513,0.0000708034,0.00006388657,0.000217699,0.00004358712,0.0005164346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3191208,"threshold_uncertainty_score":0.9779882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2191219754","doi":"10.1016/s1470-2045(15)00465-9","title":"Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":410,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; McMaster University; Juravinski Cancer Centre","funders":"Janssen Research and Development","keywords":"Bendamustine; Medicine; Rituximab; Ibrutinib; Internal medicine; Chronic lymphocytic leukemia; Placebo; Oncology; Gastroenterology; Lymphoma; Leukemia; Pathology","authors":[{"name":"Asher Chanan‐Khan","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Fatih Demırkan","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Rodrigo Santucci Silva","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Aleksander Pristupa","is_ca":false},{"name":"Ann Janssens","is_ca":false},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Halyna Pylypenko","is_ca":false},{"name":"Javier Loscertales","is_ca":false},{"name":"Abraham Avigdor","is_ca":false},{"name":"Simon Rule","is_ca":false},{"name":"Diego Villa","is_ca":true},{"name":"Olga Samoilova","is_ca":false},{"name":"Panagiots Panagiotidis","is_ca":false},{"name":"André Goy","is_ca":false},{"name":"Anthony R. Mato","is_ca":false},{"name":"Miguel Arturo Pavlovsky","is_ca":false},{"name":"Claes Karlsson","is_ca":false},{"name":"Michelle Mahler","is_ca":false},{"name":"Mariya Salman","is_ca":false},{"name":"Steven Sun","is_ca":false},{"name":"Charles E. Phelps","is_ca":false},{"name":"Sriram Balasubramanian","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1312919578447798,"gpt":0.3850341185845375,"spread":0.2537421607397577,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002799059,0.001035201,0.003595498,0.0003859696,0.0004893611,0.0001839062,0.0006850158,0.0003925034,0.00006795859],"category_scores_gemma":[0.0005225533,0.0005919786,0.0001304711,0.0009380582,0.001437531,0.000188744,0.0003947728,0.0004562396,0.00003790413],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03579395,"about_ca_system_score_gemma":0.04589505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002445562,"about_ca_topic_score_gemma":0.004994927,"domain_scores_codex":[0.9939083,0.0006927122,0.001150272,0.001451592,0.0008639209,0.001933209],"domain_scores_gemma":[0.9937594,0.002371019,0.0006060019,0.001485323,0.0007479307,0.001030359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9775483,0.004635626,0.0006297493,0.001226355,0.001649132,0.002001024,0.003070029,0.0002571126,0.0001017214,0.0001027447,0.002020011,0.00675817],"study_design_scores_gemma":[0.866789,0.04515382,0.0001285861,0.0004681236,0.00267764,0.008700125,0.001665351,0.06949015,0.0003478563,0.00002738809,0.00387004,0.0006819614],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788823,0.002192649,0.0002285258,0.0009928191,0.0001428096,0.01585198,0.00008431864,0.000352688,0.001271922],"genre_scores_gemma":[0.9916122,0.0003269653,0.001722249,0.0005654421,0.0008028185,0.003102412,0.0002519831,0.0002084521,0.001407457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1107594,"threshold_uncertainty_score":0.9996532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136242714","doi":"10.1200/jco.2005.05.0401","title":"Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Internal medicine; Fludarabine; Chronic lymphocytic leukemia; Refractory (planetary science); Rituximab; Gastroenterology; Adverse effect; Phases of clinical research; Progressive disease; Oncology; Surgery; Clinical trial; Leukemia; Multiple myeloma; Toxicity; Chemotherapy; Lymphoma; Cyclophosphamide","authors":[{"name":"Asher Chanan‐Khan","is_ca":true},{"name":"Kena C. Miller","is_ca":true},{"name":"Laurie Musial","is_ca":true},{"name":"David Lawrence","is_ca":true},{"name":"Swaminathan P. Iyer","is_ca":true},{"name":"Kenichi Takeshita","is_ca":true},{"name":"Carl W. Porter","is_ca":true},{"name":"David W. Goodrich","is_ca":true},{"name":"Zale P. Bernstein","is_ca":true},{"name":"Paul K. Wallace","is_ca":true},{"name":"David Spaner","is_ca":true},{"name":"Alice Mohr","is_ca":true},{"name":"Catriona Byrne","is_ca":true},{"name":"Francisco J. Hernandez‐Ilizaliturri","is_ca":true},{"name":"Cynthia Chrystal","is_ca":true},{"name":"Petr Starostik","is_ca":true},{"name":"Myron S. Czuczman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08788936020811099,"gpt":0.4740014396404239,"spread":0.3861120794323129,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01225504,0.0003162267,0.004192993,0.0005054991,0.00004540148,0.000005639384,0.0005402573,0.0008066954,0.00009619612],"category_scores_gemma":[0.02078681,0.0001943784,0.0007085562,0.0007089235,0.001030574,0.0001742188,0.0002319274,0.002076835,0.00000916746],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0327323,"about_ca_system_score_gemma":0.1395428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001007493,"about_ca_topic_score_gemma":0.0007163755,"domain_scores_codex":[0.9848801,0.001851455,0.01053657,0.0005437866,0.001607955,0.0005800682],"domain_scores_gemma":[0.9785803,0.01273249,0.005975846,0.0008302148,0.001397506,0.0004836444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6936935,0.07128906,0.1234734,0.0003084982,0.001527538,0.004782386,0.0003631789,0.001134545,0.0001290151,0.00001718336,0.006439058,0.09684259],"study_design_scores_gemma":[0.514143,0.2549353,0.2254763,0.000604596,0.0005839709,0.0001096178,0.000100928,0.0008113025,0.00007255774,0.00001873883,0.003004647,0.0001390718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968373,0.000282214,0.0000160762,0.00019956,0.0005876893,0.00115655,0.00001379256,0.00001153224,0.0008953069],"genre_scores_gemma":[0.9970623,0.0002418477,0.0009500184,0.0001377796,0.001033265,0.000005836869,0.00001200308,0.00004748362,0.0005094371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1836462,"threshold_uncertainty_score":0.9874615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2275948481","doi":"10.1182/blood-2004-03-0796","title":"Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"State University of New York Upstate Medical University; University of North Carolina at Chapel Hill; University of Illinois at Urbana-Champaign; Virginia Commonwealth University; McGill University; Syracuse University; University of Pittsburgh; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; University of Rochester; University of Miami; York University; University of Missouri; Georgetown University; National Cancer Institute; Wake Forest University; University of Pennsylvania; Dartmouth College; State University of New York; University of Nebraska Medical Center; Kaiser Permanente; University of South Carolina; University of Minnesota; Massachusetts General Hospital; University of Pretoria; Ohio State University; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Rituximab; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Leukemia; Surgery; Chemotherapy; Lymphoma; Cyclophosphamide","authors":[{"name":"J. C. Byrd","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0119435218848345,"gpt":0.2820362234149799,"spread":0.2700927015301454,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004377413,0.0003651249,0.001451317,0.0006428065,0.00006761049,0.00002341109,0.0001910738,0.0002010708,0.00005808189],"category_scores_gemma":[0.0001603472,0.0002867627,0.0000778647,0.001682734,0.0004135346,0.0002109142,0.0001857248,0.0002642813,0.000001900991],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01586648,"about_ca_system_score_gemma":0.006414172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006336134,"about_ca_topic_score_gemma":0.005206979,"domain_scores_codex":[0.9968052,0.0002101587,0.0006623557,0.0007564855,0.001013021,0.0005527691],"domain_scores_gemma":[0.9979692,0.0000963871,0.0002863857,0.0006997027,0.0006034367,0.0003448497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01923085,0.008001764,0.9499633,0.001155447,0.007038416,0.0004415494,0.005892092,0.003373777,0.002976386,0.0007030879,0.00006723675,0.001156078],"study_design_scores_gemma":[0.1604648,0.005918853,0.8203126,0.00058542,0.002007808,0.00002302489,0.000153526,0.004167995,0.006005715,0.00005246705,0.000003463888,0.0003043136],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971381,0.0003004819,0.00002333831,0.00003600129,0.00002120278,0.00196575,0.000306646,0.00004514022,0.000163357],"genre_scores_gemma":[0.9982571,0.00003773211,0.0006100383,0.00001215843,0.00003043965,0.00007735883,0.0009200021,0.00003284328,0.00002233542],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.141234,"threshold_uncertainty_score":0.9999585,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3029637120","doi":"10.1200/jco.19.03355","title":"ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"","keywords":"Bendamustine; Idelalisib; Medicine; Rituximab; Chronic lymphocytic leukemia; Refractory (planetary science); Internal medicine; Oncology; Leukemia; Lymphoma; Ibrutinib","authors":[{"name":"Paolo Ghia","is_ca":false},{"name":"Andrzej Pluta","is_ca":false},{"name":"Małgorzata Wach","is_ca":false},{"name":"Daniel Lysák","is_ca":false},{"name":"Tomáš Kozák","is_ca":false},{"name":"Martin Šimkovič","is_ca":false},{"name":"Polina Kaplan","is_ca":false},{"name":"Iryna Kraychok","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Sean Dolan","is_ca":true},{"name":"Phillip L. Campbell","is_ca":false},{"name":"Gerardo Musuraca","is_ca":false},{"name":"Abraham Jacob","is_ca":false},{"name":"Eric J. Avery","is_ca":false},{"name":"Jae Hoon Lee","is_ca":false},{"name":"Wei Liang","is_ca":false},{"name":"Priti Patel","is_ca":false},{"name":"Cheng S. Quah","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2071622178590186,"gpt":0.5057558719860992,"spread":0.2985936541270806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01395224,0.0006166607,0.01077288,0.0005521682,0.00008113246,0.00002834777,0.001005794,0.00164734,0.002367613],"category_scores_gemma":[0.09644115,0.000399206,0.001945485,0.001110217,0.001546212,0.0002835259,0.0004001073,0.004031182,0.0001101105],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.09414819,"about_ca_system_score_gemma":0.3538572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008635644,"about_ca_topic_score_gemma":0.0002941194,"domain_scores_codex":[0.9821843,0.00267039,0.01105176,0.000846517,0.002114411,0.001132663],"domain_scores_gemma":[0.9604957,0.03042021,0.005605872,0.0007982539,0.001028312,0.001651676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9460105,0.003717092,0.000001847768,0.0004121599,0.001340236,0.0109132,0.0004863626,0.0006304926,0.0001837809,0.00005570946,0.008368178,0.02788048],"study_design_scores_gemma":[0.8185261,0.07638508,0.000006056435,0.0005387063,0.001533876,0.0007524462,0.0002826987,0.08024427,0.0001902563,0.00003618706,0.02119799,0.0003063109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823403,0.00212585,0.0003530938,0.004787802,0.004361278,0.00328856,0.00002840167,0.00006474442,0.002649967],"genre_scores_gemma":[0.9846014,0.00417642,0.002227983,0.001764313,0.006123945,0.00006143848,0.00002744701,0.0001081234,0.0009089108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.259709,"threshold_uncertainty_score":0.999846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130979463","doi":"10.1038/ng.479","title":"Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk","year":2009,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Versus Arthritis; National Heart, Lung, and Blood Institute","keywords":"Single-nucleotide polymorphism; Genome-wide association study; Biology; Genetics; Rheumatoid arthritis; Genetic association; Replication (statistics); Arthritis; Gene; Bioinformatics; Genotype; Immunology; Virology","authors":[{"name":"Soumya Raychaudhuri","is_ca":false},{"name":"Brian Thomson","is_ca":false},{"name":"Elaine F. Remmers","is_ca":false},{"name":"Stephen Eyre","is_ca":false},{"name":"Anne Hinks","is_ca":false},{"name":"Candace Guiducci","is_ca":false},{"name":"Joseph J. Catanese","is_ca":false},{"name":"Gang Xie","is_ca":true},{"name":"Eli A. Stahl","is_ca":false},{"name":"Robert Chen","is_ca":false},{"name":"Lars Alfredsson","is_ca":false},{"name":"Christopher I. Amos","is_ca":false},{"name":"Kristin Ardlie","is_ca":false},{"name":"Anne Barton","is_ca":false},{"name":"John Bowes","is_ca":false},{"name":"Noël P. Burtt","is_ca":false},{"name":"Monica Chang","is_ca":false},{"name":"Jonathan Coblyn","is_ca":false},{"name":"Karen H. Costenbader","is_ca":false},{"name":"Lindsey A. Criswell","is_ca":false},{"name":"J. Bart A. Crusius","is_ca":false},{"name":"Jing Cui","is_ca":false},{"name":"Phillip L. De Jager","is_ca":false},{"name":"Bo Ding","is_ca":false},{"name":"Paul Emery","is_ca":false},{"name":"Edward Flynn","is_ca":false},{"name":"Pille Harrison","is_ca":false},{"name":"Lynne J. Hocking","is_ca":false},{"name":"T. Huizinga","is_ca":false},{"name":"Daniel L. Kastner","is_ca":false},{"name":"Xiayi Ke","is_ca":false},{"name":"Fina Kurreeman","is_ca":false},{"name":"Annette T. Lee","is_ca":false},{"name":"Xiangdong Liu","is_ca":true},{"name":"Yonghong Li","is_ca":false},{"name":"Paul Martin","is_ca":false},{"name":"Ann W Morgan","is_ca":false},{"name":"Leonid Padyukov","is_ca":false},{"name":"David M. Reid","is_ca":false},{"name":"Mark Seielstad","is_ca":false},{"name":"Michael F. Seldin","is_ca":false},{"name":"Nancy A. Shadick","is_ca":false},{"name":"Sophia Steer","is_ca":false},{"name":"Paul P. Tak","is_ca":false},{"name":"Wendy Thomson","is_ca":false},{"name":"Annette H M van der Helm–van Mil","is_ca":false},{"name":"Irene E. van der Horst‐Bruinsma","is_ca":false},{"name":"Michael E. Weinblatt","is_ca":false},{"name":"Anthony G. Wilson","is_ca":false},{"name":"Gertjan Wolbink","is_ca":false},{"name":"P Wordsworth","is_ca":false},{"name":"David Altshuler","is_ca":false},{"name":"Elizabeth W. Karlson","is_ca":false},{"name":"René E. M. Toes","is_ca":false},{"name":"Niek de Vries","is_ca":false},{"name":"Ann B. Begovich","is_ca":false},{"name":"Katherine Siminovitch","is_ca":true},{"name":"Jane Worthington","is_ca":false},{"name":"Lars Klareskog","is_ca":false},{"name":"Peter K. Gregersen","is_ca":false},{"name":"Mark J. Daly","is_ca":false},{"name":"Robert M. Plenge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007128330863492305,"gpt":0.253852568177397,"spread":0.2467242373139047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002602118,0.0003235117,0.0005094397,0.0001338609,0.0002038698,0.00005538174,0.0001802393,0.0007162659,0.00008969334],"category_scores_gemma":[0.000616129,0.000266189,0.00006922096,0.0004220074,0.0001718376,0.00003588565,0.0001093083,0.001003531,0.00003790477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003069752,"about_ca_system_score_gemma":0.001533027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000341113,"about_ca_topic_score_gemma":0.0003447951,"domain_scores_codex":[0.997334,0.0001043179,0.0003332634,0.0006088386,0.0009368614,0.000682718],"domain_scores_gemma":[0.9982793,0.0001493482,0.0002083847,0.0006497749,0.0003093312,0.0004038541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003640868,0.001834198,0.6852694,0.0004180677,0.002078772,0.01378204,0.002503421,0.0008509198,0.004530741,0.0001373584,0.05884664,0.2261075],"study_design_scores_gemma":[0.02483683,0.001327965,0.9540443,0.0007841969,0.000136277,0.002805803,0.00005258774,0.006461097,0.002582801,0.0003401545,0.006131479,0.000496524],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633642,0.03415649,0.00003905382,0.0004199798,0.000125896,0.000623015,0.00006013733,0.00009967488,0.001111586],"genre_scores_gemma":[0.9782202,0.01786934,0.002097146,0.0007484499,0.0001767493,0.0000111851,0.00004349544,0.00005756846,0.0007759156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2687748,"threshold_uncertainty_score":0.999979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3082899459","doi":"10.1016/s1470-2045(20)30443-5","title":"Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"F. Hoffmann-La Roche; AbbVie","keywords":"Obinutuzumab; Chlorambucil; Venetoclax; Medicine; Internal medicine; Oncology; Chronic lymphocytic leukemia; Fludarabine; Open label; Clinical trial; Chemotherapy; Leukemia; Cyclophosphamide","authors":[{"name":"Othman Al‐Sawaf","is_ca":false},{"name":"Can Zhang","is_ca":false},{"name":"Maneesh Tandon","is_ca":false},{"name":"Arijit Sinha","is_ca":false},{"name":"Anna‐Maria Fink","is_ca":false},{"name":"Sandra Robrecht","is_ca":false},{"name":"Olga Samoylova","is_ca":false},{"name":"Anna Marina Liberati","is_ca":false},{"name":"Javier Pinilla‐Ibarz","is_ca":false},{"name":"Stephen Opat","is_ca":false},{"name":"Liliya Sivcheva","is_ca":false},{"name":"Katell Le Dû","is_ca":false},{"name":"Laura Fogliatto","is_ca":false},{"name":"Carsten Utoft Niemann","is_ca":false},{"name":"Robert Weinkove","is_ca":false},{"name":"Sue Robinson","is_ca":true},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Eugen Tausch","is_ca":false},{"name":"William Schary","is_ca":false},{"name":"Matthias Ritgen","is_ca":false},{"name":"Clemens‐Martin Wendtner","is_ca":false},{"name":"Karl-Anton Kreuzer","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Michael Hallek","is_ca":false},{"name":"Kirsten Fischer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2241489103395237,"gpt":0.4279868705273332,"spread":0.2038379601878094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002015741,0.0008465023,0.003387992,0.0001268728,0.0004735669,0.0002302109,0.002290241,0.0007596834,0.0004096374],"category_scores_gemma":[0.006604707,0.0006313731,0.0004215971,0.0008043686,0.0006079522,0.0002566303,0.0009962927,0.0009958685,0.000567469],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.4978594,"about_ca_system_score_gemma":0.2760753,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01265212,"about_ca_topic_score_gemma":0.002069114,"domain_scores_codex":[0.9924024,0.001011216,0.001725174,0.00171813,0.0009386097,0.0022045],"domain_scores_gemma":[0.9896625,0.006108528,0.0008142917,0.002057587,0.000434615,0.0009225249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9329637,0.0001035194,1.981741e-7,0.0003114744,0.001320626,0.0007789631,0.003773261,0.005083232,0.00146957,0.0000972011,0.04900737,0.005090915],"study_design_scores_gemma":[0.5743297,0.01299803,3.792801e-7,0.0001703181,0.00108105,0.00006721642,0.0002521997,0.338947,0.001047077,0.00005175523,0.07068523,0.0003700723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9568092,0.003390255,0.0003179706,0.00386397,0.003487822,0.02547128,0.001061138,0.000522562,0.005075778],"genre_scores_gemma":[0.9764201,0.00162171,0.001293841,0.003023563,0.008690153,0.003311826,0.002247887,0.0002591708,0.003131734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.358634,"threshold_uncertainty_score":0.9996138,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2944582362","doi":"10.1056/nejmoa1901981","title":"Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"NeuroRx Research (Canada); University of Toronto; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Placebo; Multiple sclerosis; Medicine; Bruton's tyrosine kinase; Internal medicine; Clinical trial; Oncology; Pharmacology; Alternative medicine; Immunology; Pathology; Tyrosine kinase","authors":[{"name":"Xavier Montalbán","is_ca":true},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Martin S. Weber","is_ca":true},{"name":"Ivan Staikov","is_ca":true},{"name":"Karolina Piasecka‐Stryczynska","is_ca":true},{"name":"Jonathan Willmer","is_ca":true},{"name":"Emily C. Martin","is_ca":true},{"name":"Fernando Dangond","is_ca":true},{"name":"Sana Syed","is_ca":true},{"name":"Jerry S. Wolinsky","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04527378136246739,"gpt":0.3088913223947608,"spread":0.2636175410322934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003242413,0.0001863807,0.001461273,0.0005411264,0.0000175638,0.000007000184,0.0002115562,0.0001387633,0.0005638839],"category_scores_gemma":[0.002472783,0.000114274,0.0001576846,0.0003214288,0.0001321021,0.000157398,0.00003535396,0.0005638629,0.0000129201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001424534,"about_ca_system_score_gemma":0.004559037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007056457,"about_ca_topic_score_gemma":0.0001673003,"domain_scores_codex":[0.9967551,0.0002710378,0.001225422,0.0001876812,0.001226557,0.0003341688],"domain_scores_gemma":[0.9974899,0.000946257,0.0004731387,0.0003345602,0.000288345,0.0004677755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9300771,0.0005770772,0.002931915,0.0001248015,0.0001914953,0.0004200682,0.001182184,0.0001241678,0.02483534,0.00001966083,0.001591799,0.03792435],"study_design_scores_gemma":[0.9771411,0.01230235,0.0009627941,0.001043083,0.0001588499,0.000684223,0.0002515001,0.003425531,0.002328587,0.00006423552,0.001545007,0.00009272791],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947636,0.0004472264,0.00002544621,0.001389456,0.001039575,0.001298866,0.000001228662,0.000008156319,0.001026415],"genre_scores_gemma":[0.9944869,0.0001757392,0.0004593061,0.0001377082,0.003970768,0.000005524516,0.000004695641,0.00002613264,0.0007332739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04706397,"threshold_uncertainty_score":0.8087536,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3007925874","doi":"10.1182/blood.2019002936","title":"Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Juno Therapeutics; University of British Columbia; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Celgene","keywords":"Ibrutinib; Bruton's tyrosine kinase; Medicine; Internal medicine; Oncology; Chronic lymphocytic leukemia; Leukemia; Tyrosine kinase; Receptor","authors":[{"name":"Jordan Gauthier","is_ca":false},{"name":"Alexandre V. Hirayama","is_ca":false},{"name":"Janaki Purushe","is_ca":false},{"name":"Kevin A. Hay","is_ca":true},{"name":"James Lymp","is_ca":false},{"name":"Daniel H. Li","is_ca":false},{"name":"Cecilia C.S. Yeung","is_ca":false},{"name":"Alyssa Sheih","is_ca":false},{"name":"Barbara S. Pender","is_ca":false},{"name":"Reed M. Hawkins","is_ca":false},{"name":"Aesha Vakil","is_ca":false},{"name":"Tinh-Doan Phi","is_ca":false},{"name":"Rachel N. Steinmetz","is_ca":false},{"name":"Mazyar Shadman","is_ca":false},{"name":"Stanley R. Riddell","is_ca":false},{"name":"David G. Maloney","is_ca":false},{"name":"Cameron J. Turtle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02987095647810029,"gpt":0.2892506916692684,"spread":0.2593797351911681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001982111,0.0002198905,0.0005267954,0.00004415605,0.0000377836,0.00001777746,0.0001237605,0.000125759,0.0001127095],"category_scores_gemma":[0.0003141839,0.0001651304,0.0001185277,0.000214783,0.00026479,0.00004805245,0.0001026694,0.0002113022,0.00001297739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003928822,"about_ca_system_score_gemma":0.00219429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003658892,"about_ca_topic_score_gemma":0.00001711427,"domain_scores_codex":[0.9982238,0.00005376671,0.0003583629,0.0005362146,0.000409848,0.0004179921],"domain_scores_gemma":[0.9985838,0.0002951573,0.00009986978,0.0003987516,0.0002096034,0.0004128197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06351136,0.01932682,0.2702834,0.03422838,0.005522636,0.001589476,0.02642965,0.00008459884,0.5472116,0.0005647201,0.02004405,0.01120329],"study_design_scores_gemma":[0.3933714,0.006578411,0.03625388,0.0006826943,0.001803865,0.0002282868,0.000688046,0.002398029,0.5411191,0.00002891936,0.0160711,0.0007762602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960261,0.001006915,0.0001188669,0.000615891,0.00004101804,0.00186986,0.0001494728,0.00005593394,0.0001159442],"genre_scores_gemma":[0.9974024,0.00002931966,0.001944971,0.0002244004,0.0001910291,0.00006575212,0.00004530372,0.00003863873,0.00005816756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3298601,"threshold_uncertainty_score":0.6733823,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070487917","doi":"10.3109/10428194.2015.1022770","title":"Management of adverse events associated with idelalisib treatment: expert panel opinion","year":2015,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead Sciences","keywords":"Idelalisib; Medicine; Adverse effect; Internal medicine; Diarrhea; Intensive care medicine; Ibrutinib","authors":[{"name":"Steven Coutré","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false},{"name":"Sven de Vos","is_ca":false},{"name":"Richard R. Furman","is_ca":false},{"name":"Michael J. Keating","is_ca":false},{"name":"Daniel Li","is_ca":true},{"name":"Susan O’Brien","is_ca":false},{"name":"John M. Pagel","is_ca":false},{"name":"Martin Poleski","is_ca":false},{"name":"Jeff P. Sharman","is_ca":false},{"name":"Nai-Shun Yao","is_ca":false},{"name":"Andrew D. Zelenetz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07781209335968814,"gpt":0.3511248248391235,"spread":0.2733127314794354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009679971,0.002398019,0.006387891,0.0009933211,0.0003054323,0.00004630254,0.0009583418,0.001812875,0.0001089905],"category_scores_gemma":[0.0001258164,0.001759681,0.001348235,0.001866215,0.000746071,0.0003754091,0.0006755177,0.0003302151,0.0001848982],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2022216,"about_ca_system_score_gemma":0.05651086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002856337,"about_ca_topic_score_gemma":0.00004105363,"domain_scores_codex":[0.9899365,0.00059492,0.002508818,0.002376053,0.002585918,0.001997744],"domain_scores_gemma":[0.9932269,0.0005730712,0.001614646,0.002539071,0.0005708447,0.001475458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001132478,0.0008034048,0.00004409983,0.01709248,0.006317613,0.00336833,0.0006428214,0.00001408533,0.000001659329,0.0002947546,0.001737145,0.9685512],"study_design_scores_gemma":[0.08059497,0.002098282,0.0003141187,0.05741021,0.005439396,0.004573909,0.0006116335,0.001026831,0.00003331022,0.00006613946,0.8459325,0.001898677],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01091514,0.9755473,0.0000254007,0.00002047829,0.0005868771,0.004494747,0.0003527202,0.0003710089,0.007686339],"genre_scores_gemma":[0.003213077,0.9844794,0.0006217107,0.000110165,0.0004814593,0.001039611,0.002423804,0.0005357206,0.007095058],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9666525,"threshold_uncertainty_score":0.999483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074584895","doi":"10.1182/blood-2010-03-275420","title":"Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Amgen","keywords":"Alemtuzumab; Fludarabine; Medicine; Transplantation; Internal medicine; Chronic lymphocytic leukemia; Minimal residual disease; Oncology; Leukemia; Immunology; Cyclophosphamide; Chemotherapy","authors":[{"name":"Peter Dreger","is_ca":false},{"name":"Hartmut Döhner","is_ca":false},{"name":"Matthias Ritgen","is_ca":false},{"name":"Sebastian Böttcher","is_ca":false},{"name":"Raymonde Busch","is_ca":false},{"name":"Sascha Dietrich","is_ca":false},{"name":"Donald Bunjes","is_ca":false},{"name":"Sandra Cohen","is_ca":true},{"name":"Jörg Schubert","is_ca":false},{"name":"Ute Hegenbart","is_ca":false},{"name":"Dietrich W. Beelen","is_ca":false},{"name":"Matthias Zeis","is_ca":false},{"name":"Michael Stadler","is_ca":false},{"name":"Justin Hasenkamp","is_ca":false},{"name":"Lutz Uharek","is_ca":false},{"name":"Christof Scheid","is_ca":false},{"name":"Andreas Humpe","is_ca":false},{"name":"Thorsten Zenz","is_ca":false},{"name":"Dirk Winkler","is_ca":false},{"name":"Michael Hallek","is_ca":false},{"name":"Michael Kneba","is_ca":false},{"name":"Norbert Schmitz","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01688420731791969,"gpt":0.3061873217614207,"spread":0.289303114443501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002020451,0.0003024291,0.0007099499,0.0001478201,0.0001210948,0.00004214978,0.0003654327,0.0002677456,0.00001331382],"category_scores_gemma":[0.0002909197,0.0002108875,0.0002264729,0.0002852622,0.0004268768,0.00012682,0.00009146001,0.0007793345,0.00001083708],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003484027,"about_ca_system_score_gemma":0.01512307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001423058,"about_ca_topic_score_gemma":0.003836281,"domain_scores_codex":[0.9960058,0.000681698,0.001281671,0.0007287038,0.0007507028,0.000551448],"domain_scores_gemma":[0.9973223,0.0008784533,0.0003792408,0.0009488284,0.0001028273,0.0003683951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2153468,0.008979539,0.739154,0.003108084,0.0008171342,0.002648086,0.002373502,0.0001360357,0.01989053,0.00002760283,0.0001371304,0.007381551],"study_design_scores_gemma":[0.6079865,0.002076353,0.3826944,0.0001913829,0.001397192,0.0001013716,0.00005821174,0.002988339,0.002273004,0.00001727709,0.00001829588,0.0001977287],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937031,0.0006730763,0.000008023466,0.00007664529,0.0003388054,0.004983667,0.0001028216,0.00004438063,0.00006953938],"genre_scores_gemma":[0.9983211,0.0006060631,0.00001739974,0.00006317782,0.0004634966,0.0001949307,0.0000290661,0.00004741481,0.0002574188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3926397,"threshold_uncertainty_score":0.9904603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033489247","doi":"10.1073/pnas.0406927102","title":"Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap","year":2004,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Leukemia and Lymphoma Society; University of Rochester; National Cancer Institute; National Institutes of Health; Valeant Pharmaceuticals International; Harvard University","keywords":"EIF4E; Guanosine; Translation (biology); Messenger RNA; Biology; Ribavirin; Protein biosynthesis; Cancer research; Cell biology; Biochemistry; Gene","authors":[{"name":"Alex Kentsis","is_ca":false},{"name":"Ivan Topisirović","is_ca":false},{"name":"Biljana Čuljković","is_ca":false},{"name":"Ling Shao","is_ca":false},{"name":"Katherine L. B. Borden","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03186481578050641,"gpt":0.3307340918583351,"spread":0.2988692760778287,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000921579,0.0001184577,0.0002574317,0.0001319114,0.0001365913,0.0000121918,0.0008123604,0.0001038752,0.00001405154],"category_scores_gemma":[0.0009627184,0.00006512431,0.0001633125,0.00116222,0.001579199,0.0003804376,0.0001175114,0.0002736818,0.000002593399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000905201,"about_ca_system_score_gemma":0.001088207,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008908125,"about_ca_topic_score_gemma":2.485639e-7,"domain_scores_codex":[0.9968635,0.00001110309,0.0004306534,0.0002142311,0.002258435,0.0002220172],"domain_scores_gemma":[0.9989343,0.000206613,0.0003530863,0.00002156195,0.0004279152,0.00005648699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006755825,0.0001884495,0.0002655664,0.0002435289,0.00003445183,1.1651e-8,0.0007399534,0.000146677,0.9931632,0.003887655,0.001066657,0.0001963045],"study_design_scores_gemma":[0.002696046,0.0001075933,0.006185245,0.0002432946,0.00004414725,0.00002630058,0.000200528,0.001741935,0.9816403,0.006765281,0.0002834922,0.00006579696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882395,0.0002726673,0.00000133394,0.008999641,0.00001979035,0.0004146978,0.00005048034,0.00001067666,0.001991251],"genre_scores_gemma":[0.9992998,0.00008228347,0.0001894793,0.0002360588,0.0000740665,0.00001249343,0.000001176985,0.000006547833,0.00009804316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01152285,"threshold_uncertainty_score":0.5818623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2902460563","doi":"10.1200/jco.18.01580","title":"Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Genentech; Universiteit van Amsterdam","keywords":"Venetoclax; Rituximab; Bendamustine; Medicine; Internal medicine; Minimal residual disease; Hazard ratio; Gastroenterology; Neutropenia; Refractory (planetary science); Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Lymphoma; Confidence interval","authors":[{"name":"Arnon P. Kater","is_ca":false},{"name":"John F. Seymour","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Anton W. Langerak","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Maria Verdugo","is_ca":false},{"name":"Jenny Wu","is_ca":false},{"name":"Elizabeth A. Punnoose","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Jue Wang","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"Kathryn Humphrey","is_ca":false},{"name":"Mehrdad Mobasher","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07805887314922061,"gpt":0.4367975780317877,"spread":0.3587387048825671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003740905,0.000251033,0.001936567,0.0002474426,0.00007206381,0.000009564206,0.0003524767,0.0003498626,0.0000819676],"category_scores_gemma":[0.005897944,0.0001555947,0.0004001611,0.0003204149,0.001258484,0.0001282724,0.00016756,0.0006178998,0.000005697756],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03194321,"about_ca_system_score_gemma":0.1123347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001143918,"about_ca_topic_score_gemma":0.001724289,"domain_scores_codex":[0.9936304,0.001273649,0.003424868,0.0003775554,0.0008948582,0.0003986526],"domain_scores_gemma":[0.9930083,0.00296285,0.002232239,0.0005583669,0.0007899276,0.0004483789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5912629,0.03890676,0.1891995,0.001143184,0.006654707,0.005756216,0.0122458,0.000327389,0.02956155,0.0001422788,0.002016843,0.122783],"study_design_scores_gemma":[0.5565348,0.1436321,0.2846696,0.0005452648,0.001931937,0.000320797,0.001127838,0.007314072,0.002317384,0.00008764477,0.001301091,0.0002175033],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955918,0.00124247,0.000003583225,0.000908493,0.0007902609,0.001333324,0.00001361447,0.000007815021,0.000108676],"genre_scores_gemma":[0.9981108,0.0004722024,0.000100067,0.0001227631,0.0008873806,0.00002445458,0.000005523119,0.00003043473,0.0002464123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1225654,"threshold_uncertainty_score":0.971773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2558871324","doi":"10.1182/blood-2016-01-689422","title":"Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Alberta; University of Manitoba","funders":"National Cancer Institute; Cancer Research UK","keywords":"Medicine; Intensive care medicine; Pancytopenia; Minimal residual disease; Clinical trial; Disease; Transplantation; Disease management; Quality of life (healthcare); Leukemia; Immunology; Internal medicine; Nursing","authors":[{"name":"Michael R. Grever","is_ca":false},{"name":"Omar Abdel‐Wahab","is_ca":false},{"name":"Leslie A. Andritsos","is_ca":false},{"name":"Versha Banerji","is_ca":true},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"James S. Blachly","is_ca":false},{"name":"Timothy G. Call","is_ca":false},{"name":"Daniel Catovsky","is_ca":false},{"name":"Claire Dearden","is_ca":false},{"name":"Judit Demeter","is_ca":false},{"name":"Monica Else","is_ca":false},{"name":"Francesco Forconi","is_ca":false},{"name":"Alessandro Gozzetti","is_ca":false},{"name":"Anthony D. Ho","is_ca":false},{"name":"James B. Johnston","is_ca":true},{"name":"Jeffrey A. Jones","is_ca":false},{"name":"Gunnar Juliusson","is_ca":false},{"name":"Eric H. Kraut","is_ca":false},{"name":"Robert J. Kreitman","is_ca":false},{"name":"Loree Larratt","is_ca":true},{"name":"Francesco Lauria","is_ca":false},{"name":"Gerard Lozanski","is_ca":false},{"name":"Emili Montserrat","is_ca":false},{"name":"Sameer A. Parikh","is_ca":false},{"name":"Jae H. Park","is_ca":false},{"name":"Aaron Polliack","is_ca":false},{"name":"Graeme Quest","is_ca":true},{"name":"Farhad Ravandi","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Alan Saven","is_ca":false},{"name":"John F. Seymour","is_ca":false},{"name":"Tamar Tadmor","is_ca":false},{"name":"Martin S. Tallman","is_ca":false},{"name":"Constantine S. Tam","is_ca":false},{"name":"Enrico Tiacci","is_ca":false},{"name":"Xavier Troussard","is_ca":false},{"name":"Clive S. Zent","is_ca":false},{"name":"Thorsten Zenz","is_ca":false},{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Brunangelo Falini","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04892216517246414,"gpt":0.3103862414170301,"spread":0.261464076244566,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001618813,0.000102015,0.0001773478,0.00003547821,0.00004584509,0.000006172489,0.00008802355,0.00004083455,0.00002131597],"category_scores_gemma":[0.0001101649,0.00004457821,0.00004086559,0.00007598277,0.0001835132,0.00001544184,0.00007654401,0.00003328124,0.000005174515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005904706,"about_ca_system_score_gemma":0.0006676617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005712988,"about_ca_topic_score_gemma":0.00001535717,"domain_scores_codex":[0.9990606,0.0000137231,0.0002174396,0.0001961989,0.000300743,0.0002112914],"domain_scores_gemma":[0.9987283,0.0004730841,0.00007139503,0.0003392461,0.000315384,0.00007262965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.006033273,0.004985533,0.4734881,0.009548593,0.004738997,0.0003522194,0.000472636,0.00003111438,0.001449595,0.001482386,0.1934103,0.3040073],"study_design_scores_gemma":[0.5400711,0.003569622,0.2770217,0.003602438,0.00442478,0.00007288218,0.0006550351,0.001416523,0.07624645,0.0002374299,0.09198466,0.0006973177],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954858,0.001039009,0.0001258719,0.001517651,0.0000387923,0.001178824,0.00003659503,0.00001751858,0.0005598943],"genre_scores_gemma":[0.9943479,0.001052799,0.002649343,0.0001648039,0.00006693358,0.0002344629,0.000004695814,0.00002413738,0.00145493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5340379,"threshold_uncertainty_score":0.1817847,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151979638","doi":"10.1634/theoncologist.10-5-345","title":"HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes from the HER1/EGFR Inhibitor Rash Management Forum","year":2005,"lang":"en","type":"review","venue":"The Oncologist","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Rash; Medicine; Dermatology; Acne; EGFR inhibitors; Adverse effect; Etiology; Epidermal growth factor receptor; Pathology; Internal medicine; Cancer","authors":[{"name":"Román Pérez-Soler","is_ca":false},{"name":"Jean Pierre Delord","is_ca":false},{"name":"Allan C. Halpern","is_ca":false},{"name":"Karen Kelly","is_ca":false},{"name":"James G. Krueger","is_ca":false},{"name":"B. Massuti Sureda","is_ca":false},{"name":"Joachim von Pawel","is_ca":false},{"name":"Jennifer S. Temel","is_ca":false},{"name":"Salvatore Siena","is_ca":false},{"name":"Denis Soulières","is_ca":true},{"name":"Leonard B. Saltz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06765387642643766,"gpt":0.3690442441056063,"spread":0.3013903676791686,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001742594,0.0008477163,0.002094452,0.0002196557,0.0008607135,0.00021942,0.0008134564,0.0007210657,0.0001195286],"category_scores_gemma":[0.0003768025,0.0004593384,0.0007415533,0.0007671631,0.0007497151,0.0001178279,0.0008779916,0.001006151,0.0001337487],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02464092,"about_ca_system_score_gemma":0.001710903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007082001,"about_ca_topic_score_gemma":0.00202077,"domain_scores_codex":[0.9952219,0.0006560895,0.00118668,0.001000334,0.0009616412,0.0009733287],"domain_scores_gemma":[0.9954547,0.00199912,0.0007255999,0.001382029,0.0001723335,0.0002662195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008916452,0.0002956603,0.0001664224,0.004670236,0.00283228,0.00008559924,0.0003188115,0.000002887964,4.574006e-7,0.0009735762,0.1546518,0.8359131],"study_design_scores_gemma":[0.008315518,0.0001924832,0.0006919724,0.004983954,0.004231035,0.0000406461,0.001298453,0.00008448099,0.000002181252,0.0004009621,0.9792988,0.000459528],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004299894,0.9668371,0.00003665835,0.01599333,0.001892872,0.01082411,0.0003028295,0.0002890661,0.003394047],"genre_scores_gemma":[0.0003203413,0.9710605,0.0008466061,0.001818704,0.002833218,0.002669672,0.0009517524,0.0001606165,0.01933862],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8354536,"threshold_uncertainty_score":0.9997858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224138250","doi":"10.1182/bloodadvances.2021006434","title":"Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia ","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Internal medicine; Hazard ratio; Adverse effect; Oncology; Confidence interval; Leukemia; Gastroenterology; Chemotherapy; Cyclophosphamide","authors":[{"name":"Paul M. Barr","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Tadeusz Robak","is_ca":false},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Osnat Bairey","is_ca":false},{"name":"Jan A. Burger","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Steven Coutré","is_ca":false},{"name":"Claire Dearden","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Helen O. McCarthy","is_ca":false},{"name":"Jianyong Li","is_ca":false},{"name":"Fritz Offner","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Cathy Zhou","is_ca":false},{"name":"Emily Hsu","is_ca":false},{"name":"Anita Szőke","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Paolo Ghia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01781755912526684,"gpt":0.2833469322780211,"spread":0.2655293731527543,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001556672,0.0004076912,0.0006515599,0.0001835913,0.0004744885,0.00003794583,0.0003522563,0.00007427937,0.0005815467],"category_scores_gemma":[0.0001943685,0.0003191308,0.0001936559,0.0005071328,0.00009692275,0.0001510541,0.0002431325,0.0001661387,0.00008124535],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07110418,"about_ca_system_score_gemma":0.01558298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001569411,"about_ca_topic_score_gemma":0.001075776,"domain_scores_codex":[0.9966828,0.00005865959,0.0004463597,0.0009150153,0.001029796,0.0008673247],"domain_scores_gemma":[0.9979786,0.0004811561,0.0001474483,0.0008069983,0.0001851142,0.0004007086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2189756,0.007646007,0.1398528,0.004088153,0.01120686,0.002501465,0.0177683,0.09098915,0.002404806,0.001659092,0.03239895,0.4705089],"study_design_scores_gemma":[0.2854659,0.02341206,0.001687272,0.0003358521,0.0008683968,0.0000550033,0.0005060699,0.005382934,0.007415304,0.0002517837,0.6738424,0.0007770137],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908908,0.003715027,0.0001214614,0.0002416997,0.0006442418,0.003089224,0.0006769529,0.0001664774,0.0004541434],"genre_scores_gemma":[0.9869521,0.0003818549,0.001832689,0.0002875007,0.0004930144,0.001934256,0.0007704765,0.0001205604,0.007227581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6414434,"threshold_uncertainty_score":0.9999261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889729436","doi":"10.1016/j.molcel.2018.08.005","title":"Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease","year":2018,"lang":"en","type":"review","venue":"Molecular Cell","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria","funders":"Canadian Institutes of Health Research","keywords":"Biology; Kinase; Disease; Protein-Serine-Threonine Kinases; Phosphoinositide 3-kinase; Cell biology; Human disease; Computational biology; Signal transduction; Protein kinase A; Genetics; PI3K/AKT/mTOR pathway; Gene; Internal medicine","authors":[{"name":"John E. Burke","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04109922541070341,"gpt":0.3339861591482495,"spread":0.292886933737546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002130534,0.0002979015,0.0009645022,0.0002223227,0.00003832527,0.00001553153,0.0001326374,0.0001464399,0.0000491618],"category_scores_gemma":[0.00009129875,0.0002240903,0.0003217887,0.000186999,0.0001509064,0.00002547012,0.000125261,0.0001236129,0.000002155631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002941444,"about_ca_system_score_gemma":0.002310008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002078502,"about_ca_topic_score_gemma":0.00001702946,"domain_scores_codex":[0.9984232,0.00009077413,0.0005032305,0.0004396758,0.0002587662,0.0002843595],"domain_scores_gemma":[0.9988762,0.0001190725,0.0001989108,0.0005339471,0.00009964866,0.0001722313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006718659,0.0005429799,0.0001506103,0.5098158,0.0008103471,0.0005820162,0.0008245067,0.000018928,0.00564738,0.0008487304,0.002015122,0.4780717],"study_design_scores_gemma":[0.03019874,0.002104823,0.0004656964,0.09732886,0.004586451,0.00008958683,0.000184624,0.005269635,0.08380746,0.002110736,0.7718509,0.002002464],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03452827,0.9629363,0.00006286262,0.00001094998,0.00003781193,0.002151333,0.00008156979,0.00001159263,0.0001793182],"genre_scores_gemma":[0.07848322,0.9192275,0.0003880139,0.00006097775,0.0001190031,0.0002948279,0.0009156715,0.0001096923,0.0004011056],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7698358,"threshold_uncertainty_score":0.9138138,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2739393823","doi":"10.3324/haematol.2017.171041","title":"Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Medicine; Internal medicine; Discontinuation; Mantle cell lymphoma; Atrial fibrillation; Cumulative incidence; Adverse effect; Chronic lymphocytic leukemia; Hazard ratio; Oncology; Confidence interval; Leukemia; Lymphoma; Cohort","authors":[{"name":"Jennifer R. Brown","is_ca":false},{"name":"Javid J. Moslehi","is_ca":false},{"name":"Susan O’Brien","is_ca":false},{"name":"Paolo Ghia","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Florence Cymbalista","is_ca":false},{"name":"Tait D. Shanafelt","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Simon Rule","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Steven Coutré","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Martin Dreyling","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Michael M. Todd","is_ca":false},{"name":"Jessica Vermeulen","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Fong Clow","is_ca":false},{"name":"Lori Styles","is_ca":false},{"name":"Rudy Valentino","is_ca":false},{"name":"Mark Wildgust","is_ca":false},{"name":"Michelle Mahler","is_ca":false},{"name":"Jan A. Burger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08473874912293827,"gpt":0.384229192574077,"spread":0.2994904434511387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006915556,0.0001581445,0.003025692,0.0001701264,0.0001045504,0.00001678625,0.0001281772,0.0002371033,0.000197024],"category_scores_gemma":[0.04776195,0.000105142,0.0006761196,0.00009300716,0.0001909155,0.000166791,0.00005136739,0.0001091803,0.00001551919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006649146,"about_ca_system_score_gemma":0.001564169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002531418,"about_ca_topic_score_gemma":0.00002137134,"domain_scores_codex":[0.9959578,0.0009116168,0.002099273,0.0003002155,0.0005139425,0.0002171649],"domain_scores_gemma":[0.9948905,0.001222743,0.002873622,0.000714222,0.0002267787,0.00007219461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9573528,0.00009152105,0.008079634,0.0002953672,0.0006643411,0.0004372099,0.0002511647,0.00004634651,0.02932263,0.001826179,0.00004911648,0.001583732],"study_design_scores_gemma":[0.965139,0.000133724,0.01108166,0.0003223263,0.0004102479,0.0002504404,0.00002113143,0.01571614,0.006076631,0.0005711702,0.0001568047,0.0001206753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912586,0.00007046918,0.000273268,0.0007693705,0.000255117,0.004833202,0.000006076125,0.00003632193,0.002497541],"genre_scores_gemma":[0.9983,0.0003008815,0.0002420448,0.00001698706,0.0001988872,0.00006377079,0.0001485709,0.00001114223,0.0007177105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04084639,"threshold_uncertainty_score":0.9602591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560708148","doi":"10.1016/s1470-2045(16)30632-5","title":"Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Royal Victoria Hospital; Dalhousie University","funders":"Pharmacyclics","keywords":"Rituximab; Medicine; Ibrutinib; Internal medicine; Population; Waldenstrom macroglobulinemia; Oncology; Lymphoma; Leukemia; Chronic lymphocytic leukemia","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Judith Trotman","is_ca":false},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Jeffrey V Matous","is_ca":false},{"name":"David Macdonald","is_ca":true},{"name":"Constantine S. Tam","is_ca":false},{"name":"Olivier Tournilhac","is_ca":false},{"name":"Shuo Ma","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Leonard T. Heffner","is_ca":false},{"name":"Chaim Shustik","is_ca":true},{"name":"Ramón García‐Sánz","is_ca":false},{"name":"Robert F. Cornell","is_ca":false},{"name":"Carlos Fernández de Larrea","is_ca":false},{"name":"Jorge J. Castillo","is_ca":false},{"name":"Miquel Granell","is_ca":false},{"name":"Marie‐Christine Kyrtsonis","is_ca":false},{"name":"Véronique Leblond","is_ca":false},{"name":"Argiris Symeonidis","is_ca":false},{"name":"Efstathios Kastritis","is_ca":false},{"name":"Priyanka Singh","is_ca":false},{"name":"Jianling Li","is_ca":false},{"name":"Thorsten Graef","is_ca":false},{"name":"Elizabeth Bilotti","is_ca":false},{"name":"Steven P. Treon","is_ca":false},{"name":"Christian Buske","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1097531342863321,"gpt":0.454956165901559,"spread":0.3452030316152269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001014993,0.0002022529,0.0007796208,0.00008705579,0.00009315627,0.00002925346,0.001093122,0.0001618804,0.0002521218],"category_scores_gemma":[0.0005774178,0.000103855,0.0000337319,0.000165085,0.000392052,0.0003194936,0.0002634071,0.000203905,0.00003012881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003475532,"about_ca_system_score_gemma":0.002896732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002046026,"about_ca_topic_score_gemma":0.0001624652,"domain_scores_codex":[0.9977619,0.0002603928,0.0005112894,0.0004528933,0.000467933,0.0005456053],"domain_scores_gemma":[0.9972728,0.0006597445,0.0003463142,0.0009056244,0.000645111,0.0001703624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.794345,0.03701985,0.003163285,0.0001071745,0.0006133705,0.0001793943,0.0009003841,9.942744e-7,0.006184508,0.0009333121,0.003727429,0.1528253],"study_design_scores_gemma":[0.9372995,0.03335293,0.001855623,0.00008862187,0.0001424949,0.00005159631,0.0001229133,0.0006759244,0.001651485,0.0001313862,0.02445537,0.0001721445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927904,0.00002088051,0.00006226933,0.001513518,0.0005502639,0.00349078,0.0002195314,0.00004396584,0.001308415],"genre_scores_gemma":[0.9946985,0.00005397912,0.003001607,0.0005005107,0.0008683773,0.0002533087,0.0001866283,0.00004327385,0.0003938499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1526531,"threshold_uncertainty_score":0.9088395,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041313070","doi":"10.1016/s1535-6108(03)00136-3","title":"Escape from Cbl-mediated downregulation","year":2003,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Receptor tyrosine kinase; Endocytosis; Downregulation and upregulation; Ubiquitin; Cell biology; Biology; Receptor; Lysosome; Signal transduction; Cancer research; Genetics; Biochemistry; Gene","authors":[{"name":"Pascal Peschard","is_ca":true},{"name":"Morag Park","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01826539337311441,"gpt":0.2899037747678703,"spread":0.2716383813947559,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000103129,0.0001105695,0.000178808,0.00003367426,0.00003752886,0.00001384222,0.00006808744,0.0001055825,0.007283154],"category_scores_gemma":[0.00007894239,0.0000964395,0.00005486655,0.0001744927,0.00005310558,0.00006369501,0.00001793572,0.0001204819,0.0005023965],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007629542,"about_ca_system_score_gemma":0.003503462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002618716,"about_ca_topic_score_gemma":0.0001614736,"domain_scores_codex":[0.9989212,0.00004112555,0.0001640192,0.0002645555,0.0003228301,0.0002862549],"domain_scores_gemma":[0.9992357,0.0001036534,0.00004221194,0.0003456228,0.00008768313,0.0001850583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001448655,0.0009692892,0.02451042,0.0008951002,0.0005300134,0.0006516335,0.003721243,0.000857978,0.7125478,0.001090166,0.2185372,0.0342405],"study_design_scores_gemma":[0.04783862,0.000227612,0.01802925,0.0002306478,0.0002366527,0.00003524894,0.0004545768,0.01832272,0.3810394,0.0005347292,0.5324762,0.0005742809],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9067506,0.006524821,0.0001542533,0.0002612493,0.0003260731,0.0003754557,0.00002601656,0.0000849749,0.08549659],"genre_scores_gemma":[0.9918213,0.0005177415,0.0003966744,0.0003900836,0.0002386641,0.00004242326,0.00008818473,0.00002840057,0.006476497],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3315084,"threshold_uncertainty_score":0.99618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3088078660","doi":"10.1200/jco.20.00948","title":"Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Jewish General Hospital","funders":"National Cancer Institute; University of California, San Diego; University of Texas MD Anderson Cancer Center; National Institutes of Health; Apellis Pharmaceuticals; BeiGene; National Comprehensive Cancer Network; University of Nebraska Medical Center; Universiteit van Amsterdam; Leukemia and Lymphoma Society; Alexion Pharmaceuticals; Gilead Sciences; Teva Pharmaceutical Industries; MorphoSys; Celgene; Pharmacyclics; Genentech; California Institute for Regenerative Medicine; AstraZeneca; Loxo Oncology; TG Therapeutics; Amgen; Breast Cancer Research Foundation","keywords":"Medicine; Venetoclax; Internal medicine; Bendamustine; Rituximab; Chronic lymphocytic leukemia; Regimen; Hazard ratio; Oncology; Progression-free survival; Gastroenterology; Alemtuzumab; Minimal residual disease; Leukemia; Chemotherapy; Lymphoma; Confidence interval; Transplantation","authors":[{"name":"Arnon P. Kater","is_ca":false},{"name":"Jenny Wu","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"James D’Rozario","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Carolyn Owen","is_ca":true},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Julie Dubois","is_ca":false},{"name":"Eric Eldering","is_ca":false},{"name":"Clemens Mellink","is_ca":false},{"name":"Anne-Marie Van Der Kevie-Kersemaekers","is_ca":false},{"name":"Su Young Kim","is_ca":false},{"name":"Brenda Chyla","is_ca":false},{"name":"Elizabeth A. Punnoose","is_ca":false},{"name":"Christopher R. Bolen","is_ca":false},{"name":"Zoe J. Assaf","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Jue Wang","is_ca":false},{"name":"Marcus Lefebure","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"Kathryn Humphrey","is_ca":false},{"name":"John F. Seymour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2785272315645372,"gpt":0.5228803570445849,"spread":0.2443531254800477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007066775,0.0001488859,0.001646331,0.0001085346,0.00004245369,0.000008198866,0.0002119661,0.000246656,0.00007447821],"category_scores_gemma":[0.006806572,0.00009791143,0.0002426684,0.0002396445,0.0006946064,0.0000682865,0.0001368926,0.0007586842,0.000003468236],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.04597879,"about_ca_system_score_gemma":0.1263031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004062126,"about_ca_topic_score_gemma":0.0006035519,"domain_scores_codex":[0.9943178,0.001502245,0.002887968,0.0002843237,0.0007842846,0.0002234102],"domain_scores_gemma":[0.9925478,0.004629144,0.001631633,0.000286228,0.0005931233,0.0003120403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5136901,0.01014469,0.04675614,0.0006362555,0.01078045,0.00308753,0.04089447,0.1549159,0.04611804,0.0001102554,0.003675311,0.1691908],"study_design_scores_gemma":[0.4407714,0.0239905,0.191423,0.00009390489,0.0009238215,0.0001420437,0.0008300397,0.3413454,0.0001093452,0.0002651792,0.00003287625,0.00007251453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964168,0.001641179,0.00002272468,0.0006459331,0.000109509,0.001004825,0.00005182113,0.000003778489,0.0001034152],"genre_scores_gemma":[0.9985914,0.0004478488,0.0003806354,0.0001155122,0.0004244075,0.000006615598,0.00001452045,0.00001522358,0.000003852388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1864295,"threshold_uncertainty_score":0.9576835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108305936","doi":"10.1038/ng.2652","title":"Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia","year":2013,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"Chronic lymphocytic leukemia; Genome-wide association study; Biology; Single-nucleotide polymorphism; Locus (genetics); Genetics; Genetic association; Leukemia; Gene; Genotype","authors":[{"name":"Sonja I. Berndt","is_ca":false},{"name":"Christine F. Skibola","is_ca":false},{"name":"Joseph Vijai","is_ca":false},{"name":"Nicola J. Camp","is_ca":false},{"name":"Alexandra Nieters","is_ca":false},{"name":"Zhaoming Wang","is_ca":false},{"name":"Wendy Cozen","is_ca":false},{"name":"Alain Monnereau","is_ca":false},{"name":"Sophia Wang","is_ca":false},{"name":"Rachel S. Kelly","is_ca":false},{"name":"Qing Lan","is_ca":false},{"name":"Lauren R. Teras","is_ca":false},{"name":"Nilanjan Chatterjee","is_ca":false},{"name":"Charles C. Chung","is_ca":false},{"name":"Meredith Yeager","is_ca":false},{"name":"Angela Brooks‐Wilson","is_ca":true},{"name":"Patricia Hartge","is_ca":false},{"name":"Mark P. Purdue","is_ca":false},{"name":"Brenda M. Birmann","is_ca":false},{"name":"Bruce K. Armstrong","is_ca":false},{"name":"Pierluigi Cocco","is_ca":false},{"name":"Yawei Zhang","is_ca":false},{"name":"Gianluca Severi","is_ca":false},{"name":"Anne Zeleniuch‐Jacquotte","is_ca":false},{"name":"Charles Lawrence","is_ca":false},{"name":"Laurie Burdette","is_ca":false},{"name":"Jeffrey Yuenger","is_ca":false},{"name":"Amy Hutchinson","is_ca":false},{"name":"Kevin B. Jacobs","is_ca":false},{"name":"Timothy G. Call","is_ca":false},{"name":"Tait D. Shanafelt","is_ca":false},{"name":"Anne J. Novak","is_ca":false},{"name":"Neil E. Kay","is_ca":false},{"name":"Mark Liebow","is_ca":false},{"name":"Alice H. Wang","is_ca":false},{"name":"Karin E. Smedby","is_ca":false},{"name":"Hans‐Olov Adami","is_ca":false},{"name":"Mads Melbye","is_ca":false},{"name":"Bengt Glimelius","is_ca":false},{"name":"Ellen T. Chang","is_ca":false},{"name":"Martha Glenn","is_ca":false},{"name":"Karen Curtin","is_ca":false},{"name":"Lisa Cannon‐Albright","is_ca":false},{"name":"Brandt Jones","is_ca":false},{"name":"W. Ryan Diver","is_ca":false},{"name":"Brian K. Link","is_ca":false},{"name":"George J. Weiner","is_ca":false},{"name":"Lucía Conde","is_ca":false},{"name":"Paige M. Bracci","is_ca":false},{"name":"Jacques Riby","is_ca":false},{"name":"Elizabeth A. Holly","is_ca":false},{"name":"Martyn T. Smith","is_ca":false},{"name":"Rebecca D. Jackson","is_ca":false},{"name":"Lesley F. Tinker","is_ca":false},{"name":"Yolanda Benavente","is_ca":false},{"name":"Nikolaus Becker","is_ca":false},{"name":"Paolo Boffetta","is_ca":false},{"name":"Paul Brennan","is_ca":false},{"name":"Lenka Foretová","is_ca":false},{"name":"Marc Maynadié","is_ca":false},{"name":"James McKay","is_ca":false},{"name":"Anthony Staines","is_ca":false},{"name":"Kari G. Rabe","is_ca":false},{"name":"Sara J. Achenbach","is_ca":false},{"name":"Celine M. Vachon","is_ca":false},{"name":"Lynn R. Goldin","is_ca":false},{"name":"Sara S. Strom","is_ca":false},{"name":"Mark C. Lanasa","is_ca":false},{"name":"Logan G. Spector","is_ca":false},{"name":"José F. Leis","is_ca":false},{"name":"Julie M. Cunningham","is_ca":false},{"name":"J. Brice Weinberg","is_ca":false},{"name":"Vicki A. Morrison","is_ca":false},{"name":"Neil E. Caporaso","is_ca":false},{"name":"Aaron D. Norman","is_ca":false},{"name":"Martha S. Linet","is_ca":false},{"name":"Anneclaire J. De Roos","is_ca":false},{"name":"Lindsay M. Morton","is_ca":false},{"name":"Richard K. Severson","is_ca":false},{"name":"Elio Ríboli","is_ca":false},{"name":"Paolo Vineis","is_ca":false},{"name":"Rudolph Kaaks","is_ca":false},{"name":"Dimitrios Trichopoulos","is_ca":false},{"name":"Giovanna Masala","is_ca":false},{"name":"Elisabete Weiderpass","is_ca":false},{"name":"María‐Dolores Chirlaque","is_ca":false},{"name":"Roel Vermeulen","is_ca":false},{"name":"Ruth C. Travis","is_ca":false},{"name":"Graham G. Giles","is_ca":false},{"name":"Demetrius Albanes","is_ca":false},{"name":"Jarmo Virtamo","is_ca":false},{"name":"Stephanie J. Weinstein","is_ca":false},{"name":"Jacqueline Clavel","is_ca":false},{"name":"Tongzhang Zheng","is_ca":false},{"name":"Theodore R. Holford","is_ca":false},{"name":"Kenneth Offit","is_ca":false},{"name":"Andrew D. Zelenetz","is_ca":false},{"name":"Robert J. Klein","is_ca":false},{"name":"John J. Spinelli","is_ca":true},{"name":"Kimberly A. Bertrand","is_ca":false},{"name":"Francine Laden","is_ca":false},{"name":"Edward Giovannucci","is_ca":false},{"name":"Peter Kraft","is_ca":false},{"name":"Anne Kricker","is_ca":false},{"name":"Jennifer Turner","is_ca":false},{"name":"Claire M. Vajdic","is_ca":false},{"name":"Maria Grazia Ennas","is_ca":false},{"name":"Giovanni Maria Ferri","is_ca":false},{"name":"Lucia Miligi","is_ca":false},{"name":"Liming Liang","is_ca":false},{"name":"Joshua N. Sampson","is_ca":false},{"name":"Simon Crouch","is_ca":false},{"name":"Ju‐Hyun Park","is_ca":false},{"name":"Kari E. North","is_ca":false},{"name":"Angela Cox","is_ca":false},{"name":"John A. Snowden","is_ca":false},{"name":"Josh Wright","is_ca":false},{"name":"Ángel Carracedo","is_ca":false},{"name":"Carlos López-Otı́n","is_ca":false},{"name":"Sı́lvia Beà","is_ca":false},{"name":"Itziar Salaverría","is_ca":false},{"name":"David Martin‐García","is_ca":false},{"name":"Elı́as Campo","is_ca":false},{"name":"Joseph F. Fraumeni","is_ca":false},{"name":"Sílvia de Sanjosé","is_ca":false},{"name":"Henrik Hjalgrim","is_ca":false},{"name":"James R. Cerhan","is_ca":false},{"name":"Stephen J. Chanock","is_ca":false},{"name":"Nathaniel Rothman","is_ca":false},{"name":"Susan L. Slager","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03042199855255026,"gpt":0.3507989593304683,"spread":0.3203769607779181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001426974,0.001020271,0.003074211,0.0005359128,0.0003087354,0.0002341296,0.0008943813,0.00302731,0.0001607884],"category_scores_gemma":[0.00584848,0.0008425431,0.001175433,0.0007936143,0.0001022322,0.0000813242,0.0004409875,0.00261727,0.0007470071],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.3584157,"about_ca_system_score_gemma":0.07058612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003145289,"about_ca_topic_score_gemma":0.0002900077,"domain_scores_codex":[0.9936235,0.000413635,0.001462383,0.001380031,0.001765573,0.0013549],"domain_scores_gemma":[0.9923989,0.003161996,0.001258508,0.001790781,0.0009762002,0.0004136174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001930905,0.0004771944,0.003165051,0.1016785,0.01036852,0.0002692008,0.0008139054,0.0004819027,0.00001051344,0.000003193265,0.07052099,0.812018],"study_design_scores_gemma":[0.0142097,0.0007300701,0.0005234014,0.002143269,0.006734072,0.00004655704,0.00008301189,0.002671484,0.00002258441,0.00003344391,0.9720383,0.00076413],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009047745,0.9764521,0.00008320118,0.00001367521,0.001108312,0.01268515,0.000275849,0.0001749629,0.0001590396],"genre_scores_gemma":[0.002740485,0.9794226,0.0006186157,0.00009177363,0.002649149,0.001744472,0.001171894,0.0003493847,0.0112116],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9015173,"threshold_uncertainty_score":0.9996837,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2589157782","doi":"10.1182/blood-2016-10-742437","title":"Ventricular arrhythmias and sudden death in patients taking ibrutinib","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Ibrutinib; Medicine; Bruton's tyrosine kinase; Food and drug administration; Internal medicine; Cardiology; Ventricular fibrillation; Tyrosine kinase; Pharmacology; Leukemia; Receptor","authors":[{"name":"Benjamin L. Lampson","is_ca":false},{"name":"Lijian Yu","is_ca":false},{"name":"Robert J. Glynn","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Eric D. Jacobsen","is_ca":false},{"name":"Versha Banerji","is_ca":true},{"name":"Jeffrey A. Jones","is_ca":false},{"name":"Renata Walewska","is_ca":false},{"name":"Kerry J. Savage","is_ca":true},{"name":"Gregory F. Michaud","is_ca":false},{"name":"Javid J. Moslehi","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0279046217906631,"gpt":0.291713119591134,"spread":0.2638084978004709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002505821,0.0003212771,0.0006536318,0.0003001111,0.00009420669,0.00008956814,0.0002564533,0.0007788725,0.00009013969],"category_scores_gemma":[0.0006956824,0.0002821752,0.0001167434,0.00009341331,0.0001030912,0.00006644543,0.0002677699,0.001465123,0.00008388927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0020994,"about_ca_system_score_gemma":0.002333046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005586676,"about_ca_topic_score_gemma":0.000007858065,"domain_scores_codex":[0.9974152,0.0000745822,0.0003498437,0.0006145812,0.0008393844,0.000706371],"domain_scores_gemma":[0.9984018,0.0001372662,0.0002809993,0.0009488473,0.0001035087,0.0001275785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002579086,0.001073708,0.2106236,0.003697368,0.0009510334,0.2094613,0.0003885548,8.119014e-7,0.000009898899,0.00001523641,0.5673498,0.006170687],"study_design_scores_gemma":[0.1638595,0.0007042313,0.1439298,0.004135782,0.001133254,0.004299276,0.00001289945,0.0001569723,0.0005210013,0.0001310195,0.679966,0.001150329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9599296,0.001741864,0.000001094121,0.03110841,0.0002542765,0.001155965,0.00003419759,0.00004981172,0.005724736],"genre_scores_gemma":[0.8818285,0.0003477908,0.0004488508,0.09774555,0.01066553,0.0001720919,0.001172208,0.0003130841,0.007306444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2051621,"threshold_uncertainty_score":0.999963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205825534","doi":"10.1038/s41375-021-01485-x","title":"Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"AstraZeneca","keywords":"Obinutuzumab; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Ibrutinib; Internal medicine; Bruton's tyrosine kinase; Oncology; Clinical endpoint; Leukemia; Clinical trial; Chemotherapy; Tyrosine kinase; Cyclophosphamide","authors":[{"name":"Jeff P. Sharman","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Alan P Skarbnik","is_ca":false},{"name":"John M. Pagel","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Manali Kamdar","is_ca":false},{"name":"Talha Munir","is_ca":false},{"name":"Renata Walewska","is_ca":false},{"name":"Gillian Corbett","is_ca":false},{"name":"Laura Fogliatto","is_ca":false},{"name":"Yair Herishanu","is_ca":false},{"name":"Versha Banerji","is_ca":true},{"name":"Steven Coutré","is_ca":false},{"name":"George Follows","is_ca":false},{"name":"Patricia Walker","is_ca":false},{"name":"Karin Karlsson","is_ca":false},{"name":"Paolo Ghia","is_ca":false},{"name":"Ann Janssens","is_ca":false},{"name":"Florence Cymbalista","is_ca":false},{"name":"Jennifer A. Woyach","is_ca":false},{"name":"Emmanuelle Ferrant","is_ca":false},{"name":"William G. Wierda","is_ca":false},{"name":"Veerendra Munugalavadla","is_ca":false},{"name":"Ting Yu","is_ca":false},{"name":"Min Hui Wang","is_ca":false},{"name":"John C. Byrd","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04697134715739797,"gpt":0.3070144821862215,"spread":0.2600431350288235,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009653304,0.001593898,0.003763272,0.0009630586,0.0003393888,0.0001285834,0.001409104,0.001136861,0.0005323],"category_scores_gemma":[0.0004745331,0.001073239,0.000394516,0.002542927,0.0008602855,0.0002091031,0.001270307,0.00452124,0.00004376651],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.7647498,"about_ca_system_score_gemma":0.2727936,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0567187,"about_ca_topic_score_gemma":0.02227917,"domain_scores_codex":[0.9899402,0.0008650591,0.00198363,0.002295367,0.002725129,0.00219056],"domain_scores_gemma":[0.9940449,0.001632114,0.0008184673,0.002999203,0.0001856293,0.0003197145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.695471,0.001010753,0.03638951,0.0115793,0.01056921,0.04425064,0.04320714,0.08589248,0.0003460563,0.0001150692,0.06395216,0.007216627],"study_design_scores_gemma":[0.826987,0.01707989,0.005915364,0.003980163,0.002086134,0.001275381,0.004245053,0.08680954,0.0003050274,0.00001089734,0.04922185,0.002083711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863912,0.0008261295,0.000002062581,0.001273222,0.0007641081,0.008485844,0.00008000919,0.0001586317,0.002018821],"genre_scores_gemma":[0.9852361,0.0004349711,0.0000658186,0.003207384,0.0009027328,0.001063654,0.0003404806,0.0004083946,0.008340461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4919561,"threshold_uncertainty_score":0.9996809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2594646846","doi":"10.1016/s2352-3026(17)30019-4","title":"Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services","funders":"Gilead Sciences; Lymphoma Research Foundation","keywords":"Ofatumumab; Idelalisib; Medicine; Internal medicine; Population; IGHV@; Clinical endpoint; Chronic lymphocytic leukemia; Ibrutinib; Rituximab; Clinical trial; Oncology; Gastroenterology; Lymphoma; Leukemia","authors":[{"name":"Jeffrey A. Jones","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false},{"name":"Farrukh T. Awan","is_ca":false},{"name":"Xavier C. Badoux","is_ca":false},{"name":"Steven Coutré","is_ca":false},{"name":"Javier Loscertales","is_ca":false},{"name":"Kerry Taylor","is_ca":false},{"name":"Elisabeth Vandenberghe","is_ca":false},{"name":"Małgorzata Wach","is_ca":false},{"name":"Nina D. Wagner‐Johnston","is_ca":false},{"name":"Loïc Ysebaert","is_ca":false},{"name":"Lyndah Dreiling","is_ca":false},{"name":"Ronald L. Dubowy","is_ca":false},{"name":"Guan Xing","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Carolyn Owen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09379685803426602,"gpt":0.4174588566744332,"spread":0.3236619986401672,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001584072,0.0002198868,0.001724924,0.0001029663,0.0002464803,0.00007001057,0.0007707727,0.0001904068,0.00002600506],"category_scores_gemma":[0.001048952,0.0001371361,0.00003404752,0.0001139631,0.0006956849,0.0002139,0.0002065068,0.0002160793,0.000003488107],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004436193,"about_ca_system_score_gemma":0.006014132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001073926,"about_ca_topic_score_gemma":0.0006607085,"domain_scores_codex":[0.997902,0.0003158682,0.000586253,0.0004204661,0.000237769,0.0005376393],"domain_scores_gemma":[0.9970899,0.0008770184,0.0004428757,0.001317585,0.0001530048,0.0001196272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9847146,0.00103292,0.0001303629,0.0008155611,0.0002201241,0.000223773,0.0006057353,0.00002356741,0.001168962,0.004400827,0.0004072657,0.006256248],"study_design_scores_gemma":[0.964321,0.007899914,0.0002159866,0.0004023568,0.0002616615,0.0008493622,0.00003370324,0.0230432,0.00215308,0.0004374424,0.0002368934,0.000145382],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892958,0.0005368013,0.0001529856,0.001093879,0.00007324645,0.008108146,0.00001659135,0.00003067535,0.0006918124],"genre_scores_gemma":[0.9983819,0.0003228632,0.000285763,0.00009260706,0.000128932,0.0005162674,0.00007868112,0.00003803808,0.0001549214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02301963,"threshold_uncertainty_score":0.9996209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160542415","doi":"10.1200/jco.2006.07.8659","title":"Bortezomib Is Active in Patients With Untreated or Relapsed Waldenström's Macroglobulinemia: A Phase II Study of the National Cancer Institute of Canada Clinical Trials Group","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Neutropenia; Internal medicine; Gastroenterology; Macroglobulinemia; Waldenstrom macroglobulinemia; Discontinuation; Toxicity; Peripheral neuropathy; Cancer; Surgery; Multiple myeloma; Lymphoma","authors":[{"name":"Christine I. Chen","is_ca":true},{"name":"C. Tom Kouroukis","is_ca":true},{"name":"Darrell White","is_ca":true},{"name":"Michael Voralia","is_ca":true},{"name":"Edward A. Stadtmauer","is_ca":true},{"name":"A. Keith Stewart","is_ca":true},{"name":"Jean Powers","is_ca":true},{"name":"Wendy Walsh","is_ca":true},{"name":"Elizabeth A. Eisenhauer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.212617650926609,"gpt":0.5550014234986691,"spread":0.3423837725720601,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01609187,0.000194153,0.002904513,0.0001827644,0.0000589462,0.00000304765,0.0003772791,0.0004734146,0.0002297011],"category_scores_gemma":[0.02991284,0.00009738651,0.0003748982,0.0006508601,0.0005461972,0.0001079742,0.0001488371,0.001645542,4.017849e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008150875,"about_ca_system_score_gemma":0.09189509,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04760831,"about_ca_topic_score_gemma":0.3635285,"domain_scores_codex":[0.9890547,0.001438189,0.006930557,0.0003009573,0.001901216,0.0003743985],"domain_scores_gemma":[0.9837705,0.008171303,0.005116515,0.0002773994,0.002243681,0.0004205699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3675919,0.04473876,0.4454572,0.00008497951,0.003667736,0.001807649,0.000718366,0.0001490615,0.00005059416,0.00001907448,0.01492837,0.1207862],"study_design_scores_gemma":[0.3840853,0.07017474,0.5374634,0.0003767346,0.00077956,0.00009663308,0.0004583077,0.0002682148,0.0002076932,0.00002174355,0.005942631,0.0001250696],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951947,0.00003963551,0.000008689992,0.001822159,0.001319801,0.001172499,0.00005710591,0.000002457434,0.0003828961],"genre_scores_gemma":[0.9976043,0.0000780121,0.0002829549,0.00112422,0.000632164,0.00000733632,0.000004133919,0.00001696171,0.0002499616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3159203,"threshold_uncertainty_score":0.9956567,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3170908410","doi":"10.1158/2159-8290.cd-21-0145","title":"Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia","year":2021,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Cancer Institute; Ontario Institute for Cancer Research; National Institutes of Health; Canadian Cancer Society; Damon Runyon Cancer Research Foundation","keywords":"Enhancer; Stem cell; Biology; Cancer research; Leukemia; Lineage (genetic); Cell biology; Gene; Genetics; Gene expression","authors":[{"name":"Lindsey E. Montefiori","is_ca":false},{"name":"Sonja Bendig","is_ca":false},{"name":"Zhaohui Gu","is_ca":false},{"name":"Xiaolong Chen","is_ca":false},{"name":"Petri Pölönen","is_ca":false},{"name":"Xiaotu Ma","is_ca":false},{"name":"Alex Murison","is_ca":true},{"name":"Andy G.X. Zeng","is_ca":true},{"name":"Laura García‐Prat","is_ca":true},{"name":"Kirsten Dickerson","is_ca":false},{"name":"Ilaria Iacobucci","is_ca":false},{"name":"Sherif Abdelhamed","is_ca":false},{"name":"Ryan Hiltenbrand","is_ca":false},{"name":"Paul E. Mead","is_ca":false},{"name":"Cyrus M. Mehr","is_ca":false},{"name":"Beisi Xu","is_ca":false},{"name":"Zhongshan Cheng","is_ca":false},{"name":"Ti‐Cheng Chang","is_ca":false},{"name":"Tamara Westover","is_ca":false},{"name":"Jing Ma","is_ca":false},{"name":"Anna Stengel","is_ca":false},{"name":"Shunsuke Kimura","is_ca":false},{"name":"Chunxu Qu","is_ca":false},{"name":"Marcus B. Valentine","is_ca":false},{"name":"Marissa Rashkovan","is_ca":false},{"name":"Selina M. Luger","is_ca":false},{"name":"Mark R. Litzow","is_ca":false},{"name":"Jacob M. Rowe","is_ca":false},{"name":"Monique L. den Boer","is_ca":false},{"name":"Victoria Wang","is_ca":false},{"name":"Jun Yin","is_ca":false},{"name":"Steven M. Kornblau","is_ca":false},{"name":"Stephen P. Hunger","is_ca":false},{"name":"Mignon L. Loh","is_ca":false},{"name":"Ching‐Hon Pui","is_ca":false},{"name":"Wenjian Yang","is_ca":false},{"name":"Kristine R. Crews","is_ca":false},{"name":"Kathryn G. Roberts","is_ca":false},{"name":"Jun J. Yang","is_ca":false},{"name":"Mary V. Relling","is_ca":false},{"name":"William E. Evans","is_ca":false},{"name":"Wendy Stock","is_ca":false},{"name":"Elisabeth Paietta","is_ca":false},{"name":"Adolfo A. Ferrando","is_ca":false},{"name":"Jinghui Zhang","is_ca":false},{"name":"Wolfgang Kern","is_ca":false},{"name":"Torsten Haferlach","is_ca":false},{"name":"Gang Wu","is_ca":false},{"name":"John E. Dick","is_ca":true},{"name":"Jeffery M. Klco","is_ca":false},{"name":"Claudia Haferlach","is_ca":false},{"name":"Charles G. Mullighan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02139903256790399,"gpt":0.3059097712941333,"spread":0.2845107387262293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002197468,0.0003164003,0.0005957993,0.0001485321,0.00008855013,0.0001125877,0.0002391477,0.0002348975,0.0004593224],"category_scores_gemma":[0.00004799918,0.0002865275,0.0002302144,0.0006084639,0.0001353194,0.0004536734,0.0003343156,0.0005965999,0.00009357944],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02468153,"about_ca_system_score_gemma":0.02082837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001138034,"about_ca_topic_score_gemma":0.0003935287,"domain_scores_codex":[0.9970509,0.00009424562,0.0005269026,0.0008253632,0.0007361773,0.0007664555],"domain_scores_gemma":[0.9985182,0.0001430368,0.0001310262,0.0008188092,0.000146998,0.0002419839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007327106,0.0003313429,0.003883614,0.001275835,0.0001024745,0.00307813,0.002212554,0.00186669,0.959223,0.00001852895,0.005692694,0.02158239],"study_design_scores_gemma":[0.01177418,0.00008190583,0.00156674,0.001565877,0.00007160339,0.00008967458,0.001082098,0.001874484,0.9746531,0.00001742586,0.006875809,0.0003471471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737403,0.01983321,0.000297006,0.0001631133,0.0006801297,0.0003900709,0.00002649167,0.00006699871,0.004802659],"genre_scores_gemma":[0.9665864,0.005645535,0.0002062104,0.0006728792,0.000685282,0.0001702474,0.00004974537,0.00008423987,0.02589949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02123524,"threshold_uncertainty_score":0.9999587,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2115093629","doi":"10.1038/leu.2012.257","title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut Bergonié; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"IGHV@; Biology; Waldenstrom macroglobulinemia; Lymphoplasmacytic Lymphoma; Macroglobulinemia; Immunoglobulin heavy chain; Lymphoma; Gene rearrangement; Antibody; Cancer research; Gene; Immunology; Genetics; Chronic lymphocytic leukemia; Leukemia; Multiple myeloma","authors":[{"name":"Nathalie Gachard","is_ca":false},{"name":"Marie Parrens","is_ca":false},{"name":"Isabelle Soubeyran","is_ca":false},{"name":"Barbara Petit","is_ca":false},{"name":"Abdelghafour Marfak","is_ca":false},{"name":"David Rizzo","is_ca":false},{"name":"Manuel Devesa","is_ca":false},{"name":"Manuela Delage-Corre","is_ca":false},{"name":"V. Coste","is_ca":false},{"name":"Marie‐Pierre Laforêt","is_ca":false},{"name":"A. de Mascarel","is_ca":false},{"name":"Jean‐Philippe Merlio","is_ca":false},{"name":"K Bouabdhalla","is_ca":false},{"name":"Nöel Milpied","is_ca":false},{"name":"Pierre Soubeyran","is_ca":false},{"name":"Anna Schmitt","is_ca":false},{"name":"Dominique Bordessoule","is_ca":false},{"name":"Michel Cogné","is_ca":false},{"name":"Jean Feuillard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01437837057025398,"gpt":0.2692461794673759,"spread":0.254867808897122,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006275385,0.0004963921,0.0005635952,0.0001946659,0.0004448862,0.0002038654,0.0002477446,0.0003164676,0.0001658449],"category_scores_gemma":[0.0001827761,0.000356717,0.0001261753,0.000379658,0.0007953342,0.0003791177,0.0003433431,0.0002821086,0.0001520841],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01114019,"about_ca_system_score_gemma":0.003945166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001970027,"about_ca_topic_score_gemma":0.0002503948,"domain_scores_codex":[0.9967902,0.0001243286,0.0004820099,0.0005887129,0.000874621,0.001140173],"domain_scores_gemma":[0.9979761,0.0004345243,0.0001688878,0.0007056767,0.0001621225,0.0005526837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01245232,0.001433734,0.1700543,0.006356638,0.004596476,0.009304776,0.02714558,0.0007062786,0.04844674,0.03096636,0.08025614,0.6082806],"study_design_scores_gemma":[0.1300435,0.001294248,0.486021,0.0009744909,0.002335913,0.1606821,0.003568547,0.06275271,0.08982326,0.002643788,0.05700423,0.002856207],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815107,0.01283298,0.0001866053,0.0007374666,0.0003910547,0.0007708325,0.00003441887,0.0001431532,0.003392795],"genre_scores_gemma":[0.9895148,0.001132012,0.001280061,0.0007837529,0.0008845385,0.00009772761,0.00008340062,0.00008506997,0.006138614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6054244,"threshold_uncertainty_score":0.9998885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606627097","doi":"10.1084/jem.20160894","title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","year":2017,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Hertz Foundation; National Institutes of Health; National Science Foundation","keywords":"KRAS; Cancer research; Lymphoma; Biology; Enteropathy; Mutation; T-cell lymphoma; Genetics; Gene; Medicine; Disease; Immunology; Internal medicine","authors":[{"name":"Andrea B. Moffitt","is_ca":false},{"name":"Sarah L. Ondrejka","is_ca":false},{"name":"Matthew McKinney","is_ca":false},{"name":"Rachel E. Rempel","is_ca":false},{"name":"John R. Goodlad","is_ca":false},{"name":"Chun Huat Teh","is_ca":false},{"name":"Sirpa Leppä","is_ca":false},{"name":"Susanna Mannisto","is_ca":false},{"name":"Panu E. Kovanen","is_ca":false},{"name":"Eric Tse","is_ca":false},{"name":"Rex Au-Yeung","is_ca":false},{"name":"Yok‐Lam Kwong","is_ca":false},{"name":"Gopesh Srivastava","is_ca":false},{"name":"Javeed Iqbal","is_ca":false},{"name":"Jiayu Yu","is_ca":false},{"name":"Kikkeri N. Naresh","is_ca":false},{"name":"Diego Villa","is_ca":true},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Jonathan Said","is_ca":false},{"name":"Magdalena Czader","is_ca":false},{"name":"Amy Chadburn","is_ca":false},{"name":"Kristy L. Richards","is_ca":false},{"name":"Deepthi Rajagopalan","is_ca":false},{"name":"Nicholas S. Davis","is_ca":false},{"name":"Eileen Smith","is_ca":false},{"name":"Brooke C. Palus","is_ca":false},{"name":"Tiffany J. Tzeng","is_ca":false},{"name":"Jane Healy","is_ca":false},{"name":"Patricia Lugar","is_ca":false},{"name":"Jyotishka Datta","is_ca":false},{"name":"Cassandra Love","is_ca":false},{"name":"Shawn Levy","is_ca":false},{"name":"David B. Dunson","is_ca":false},{"name":"Yuan Zhuang","is_ca":false},{"name":"Eric D. Hsi","is_ca":false},{"name":"Sandeep S. Davé","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02151496905255839,"gpt":0.3070130836189852,"spread":0.2854981145664268,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001132098,0.0001786554,0.0007905705,0.000118352,0.0001200871,0.000007722895,0.00044619,0.00009173703,0.0002986084],"category_scores_gemma":[0.0002976705,0.0001030993,0.0001429363,0.00008461749,0.00071702,0.0001452072,0.0001188593,0.0001850074,0.000006135603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001693179,"about_ca_system_score_gemma":0.0005842647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002738151,"about_ca_topic_score_gemma":0.000002415001,"domain_scores_codex":[0.9977311,0.0001537705,0.000806571,0.0001157052,0.0009463845,0.0002464633],"domain_scores_gemma":[0.9967797,0.0001690018,0.002003214,0.0005256236,0.0003487672,0.0001737209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006154814,0.0009587732,0.003491038,0.0001381731,0.0002531048,0.00009273279,0.001398926,2.724078e-7,0.9845645,0.000004206322,0.002171041,0.0007723485],"study_design_scores_gemma":[0.05544294,0.004991614,0.02145633,0.001363572,0.0003600735,0.0004701407,0.003156642,0.00009998478,0.9118242,0.00001679073,0.0007155034,0.0001022564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920083,0.005787409,0.0000324367,0.0006006266,0.0004346322,0.0002854492,0.00001381507,0.000006001067,0.0008313073],"genre_scores_gemma":[0.9982819,0.0006042868,0.00001331336,0.0001398666,0.000343739,0.000003433953,0.000009912381,0.00002634619,0.0005772094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07274042,"threshold_uncertainty_score":0.4427603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905558559","doi":"10.1182/blood-2018-07-862953","title":"Bruton tyrosine kinase degradation as a therapeutic strategy for cancer","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Harvard University; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Bruton's tyrosine kinase; Ibrutinib; Mantle cell lymphoma; Cancer research; Tyrosine kinase; B cell; Lymphoma; Medicine; Biology; Immunology; Chronic lymphocytic leukemia; Signal transduction; Leukemia; Cell biology; Antibody","authors":[{"name":"Dennis Dobrovolsky","is_ca":false},{"name":"Eric S. Wang","is_ca":false},{"name":"Sara Morrow","is_ca":false},{"name":"Catharine Leahy","is_ca":false},{"name":"T.B. Faust","is_ca":false},{"name":"Radosław P. Nowak","is_ca":false},{"name":"Katherine A. Donovan","is_ca":false},{"name":"Guang Yang","is_ca":false},{"name":"Zhengnian Li","is_ca":false},{"name":"Eric S. Fischer","is_ca":false},{"name":"Steven P. Treon","is_ca":false},{"name":"David M. Weinstock","is_ca":false},{"name":"Nathanael S. Gray","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05432628899998896,"gpt":0.3694761640136313,"spread":0.3151498750136423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001509012,0.0001112282,0.0001649323,0.0000655411,0.00008062043,0.00002470467,0.0000869345,0.00008513338,0.0004231159],"category_scores_gemma":[0.00008338767,0.00008976023,0.0000599089,0.0001792795,0.0001083648,0.00005678911,0.00002204264,0.00007797242,0.0001152042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001240082,"about_ca_system_score_gemma":0.004102374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00124075,"about_ca_topic_score_gemma":0.0002251927,"domain_scores_codex":[0.9989964,0.00001974411,0.0001550301,0.0002452751,0.0002631352,0.0003204413],"domain_scores_gemma":[0.9992446,0.00006819481,0.00004173398,0.0002904265,0.0002360482,0.0001189614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004892001,0.005989054,0.005919431,0.001667781,0.001815903,0.0003123356,0.001534687,0.0000156216,0.5893193,0.01370595,0.01008645,0.3647415],"study_design_scores_gemma":[0.08739858,0.003386687,0.004693479,0.0002866405,0.0007802264,0.0003357307,0.0001503829,0.008750405,0.8516236,0.001636796,0.04060238,0.0003551073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932115,0.001733768,0.0002641794,0.0006910074,0.0001143132,0.000769818,0.00001428511,0.00006878568,0.003132312],"genre_scores_gemma":[0.9925237,0.0001102912,0.0003042537,0.0004869536,0.0007336995,0.0001559282,0.00003512923,0.00003244848,0.005617622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3643864,"threshold_uncertainty_score":0.7277436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970006069","doi":"10.1038/ng.626","title":"Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32","year":2010,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Follicular lymphoma; Biology; Chronic lymphocytic leukemia; Lymphoma; Genome-wide association study; Genetic association; Locus (genetics); Genetics; Leukemia; Single-nucleotide polymorphism; Immunology; Gene; Genotype","authors":[{"name":"Lucía Conde","is_ca":false},{"name":"Eran Halperin","is_ca":false},{"name":"Nicholas K. Akers","is_ca":false},{"name":"Kevin M. Brown","is_ca":false},{"name":"Karin E. Smedby","is_ca":false},{"name":"Nathaniel Rothman","is_ca":false},{"name":"Alexandra Nieters","is_ca":false},{"name":"Susan L Slager","is_ca":false},{"name":"Angela Brooks‐Wilson","is_ca":true},{"name":"Luz Agana","is_ca":false},{"name":"Jacques Riby","is_ca":false},{"name":"Jianjun Liu","is_ca":false},{"name":"Hans‐Olov Adami","is_ca":false},{"name":"Hatef Darabi","is_ca":false},{"name":"Henrik Hjalgrim","is_ca":false},{"name":"Hui-Qi Low","is_ca":false},{"name":"Keith Humphreys","is_ca":false},{"name":"Mads Melbye","is_ca":false},{"name":"Ellen T. Chang","is_ca":false},{"name":"Bengt Glimelius","is_ca":false},{"name":"Wendy Cozen","is_ca":false},{"name":"S. Scott Davis","is_ca":false},{"name":"Patricia Hartge","is_ca":false},{"name":"Lindsay M. Morton","is_ca":false},{"name":"Maryjean Schenk","is_ca":false},{"name":"Sophia Wang","is_ca":false},{"name":"Bruce K. Armstrong","is_ca":false},{"name":"Anne Kricker","is_ca":false},{"name":"Sam Milliken","is_ca":false},{"name":"Mark P. Purdue","is_ca":false},{"name":"Claire M. Vajdic","is_ca":false},{"name":"Peter Boyle","is_ca":false},{"name":"Qing Lan","is_ca":false},{"name":"Shelia Hoar Zahm","is_ca":false},{"name":"Yawei Zhang","is_ca":false},{"name":"Tongzhang Zheng","is_ca":false},{"name":"Nikolaus Becker","is_ca":false},{"name":"Yolanda Benavente","is_ca":false},{"name":"Paolo Boffetta","is_ca":false},{"name":"Paul Brennan","is_ca":false},{"name":"Katja Butterbach","is_ca":false},{"name":"Pierluigi Cocco","is_ca":false},{"name":"Lenka Foretová","is_ca":false},{"name":"Marc Maynadié","is_ca":false},{"name":"Sílvia de Sanjosé","is_ca":false},{"name":"Anthony Staines","is_ca":false},{"name":"John J. Spinelli","is_ca":true},{"name":"Sara J. Achenbach","is_ca":false},{"name":"Timothy G. Call","is_ca":false},{"name":"Nicola J. Camp","is_ca":false},{"name":"Martha Glenn","is_ca":false},{"name":"Neil E. Caporaso","is_ca":false},{"name":"James R. Cerhan","is_ca":false},{"name":"Julie M. Cunningham","is_ca":false},{"name":"Lynn R. Goldin","is_ca":false},{"name":"Curtis A. Hanson","is_ca":false},{"name":"Neil E. Kay","is_ca":false},{"name":"Mark C. Lanasa","is_ca":false},{"name":"José F. Leis","is_ca":false},{"name":"Gerald E. Marti","is_ca":false},{"name":"Kari G. Rabe","is_ca":false},{"name":"Laura Z. Rassenti","is_ca":false},{"name":"Logan G. Spector","is_ca":false},{"name":"Sara S. Strom","is_ca":false},{"name":"Celine M. Vachon","is_ca":false},{"name":"J. Brice Weinberg","is_ca":false},{"name":"Elizabeth A. Holly","is_ca":false},{"name":"Stephen J. Chanock","is_ca":false},{"name":"Martyn T. Smith","is_ca":false},{"name":"Paige M. Bracci","is_ca":false},{"name":"Christine F. Skibola","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007304496344641298,"gpt":0.2810534068355785,"spread":0.2737489104909372,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007511203,0.0002186447,0.0004342965,0.0001855421,0.000130662,0.00003309878,0.0002993588,0.0007426127,0.0001453638],"category_scores_gemma":[0.002135664,0.0001920292,0.0001540345,0.0004338667,0.00007139455,0.00003567504,0.0002750194,0.0008035918,0.0000899107],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005823082,"about_ca_system_score_gemma":0.001513046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002435687,"about_ca_topic_score_gemma":0.001273077,"domain_scores_codex":[0.9970985,0.0001106174,0.0004449391,0.0004361261,0.001455627,0.0004541911],"domain_scores_gemma":[0.9975718,0.0004036729,0.0003155702,0.0009253004,0.0005917875,0.0001918148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003955853,0.001337538,0.9428541,0.0002024129,0.0009624746,0.0002572722,0.00251684,0.0001054334,0.04364727,0.000005076345,0.004660238,0.003055766],"study_design_scores_gemma":[0.0253447,0.0007336813,0.8957889,0.000031479,0.000703763,0.00005446238,0.0005058994,0.000723744,0.05584981,0.0001967039,0.0197522,0.0003146628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948895,0.002553987,0.00001086781,0.0001293143,0.0006606723,0.0009607135,0.00002419851,0.0000484865,0.0007222456],"genre_scores_gemma":[0.9959712,0.0003724738,0.0003471795,0.0001328312,0.0003985613,0.00002728748,0.00003336026,0.00005047823,0.002666611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0470652,"threshold_uncertainty_score":0.9979934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765414225","doi":"10.1182/blood-2017-09-804641","title":"Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"Ibrutinib; Rituximab; Medicine; Follicular lymphoma; Oncology; Refractory (planetary science); Internal medicine; Idelalisib; Phases of clinical research; Clinical trial; Lymphoma; Leukemia; Chronic lymphocytic leukemia; Biology","authors":[{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Brian A. Costello","is_ca":false},{"name":"Betsy LaPlant","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Craig B. Reeder","is_ca":false},{"name":"Lim Soon Thye","is_ca":false},{"name":"Daniel M. Anderson","is_ca":false},{"name":"Kilannin Krysiak","is_ca":false},{"name":"Cody A. Ramirez","is_ca":false},{"name":"Jing Qi","is_ca":false},{"name":"Barry A. Siegel","is_ca":false},{"name":"Malachi Griffith","is_ca":false},{"name":"Obi L. Griffith","is_ca":false},{"name":"Felicia Gomez","is_ca":false},{"name":"Todd A. Fehniger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06832704270368069,"gpt":0.3612379891516637,"spread":0.292910946447983,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006876024,0.0002509413,0.0006012762,0.0001800425,0.0002136044,0.0001064818,0.0004099357,0.0002600055,0.0003478888],"category_scores_gemma":[0.003167091,0.0001964089,0.000191376,0.0001421851,0.0002844879,0.0001138211,0.0002041843,0.0002374198,0.0001846522],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003613941,"about_ca_system_score_gemma":0.007564513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005750862,"about_ca_topic_score_gemma":0.000127935,"domain_scores_codex":[0.9973622,0.0001178851,0.0005873975,0.0005552401,0.000710501,0.0006667862],"domain_scores_gemma":[0.9974312,0.0002352641,0.000257842,0.001627586,0.0001002384,0.0003479034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5387154,0.1319578,0.002296937,0.001279615,0.002029155,0.08444756,0.00260293,0.000003778814,0.109864,0.0003754591,0.01148109,0.1149463],"study_design_scores_gemma":[0.9397089,0.003279068,0.0005963329,0.0002718084,0.0002788206,0.0005796002,0.0000855897,0.0004006633,0.02646032,0.00002876002,0.02804558,0.0002645425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905085,0.0004828122,0.000005946406,0.0003914153,0.0004300159,0.001425109,0.00001288666,0.00007874607,0.006664599],"genre_scores_gemma":[0.9949816,0.00007152566,0.0003070872,0.0001612104,0.0006237699,0.0001231378,0.00002163211,0.00005438087,0.003655592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4009935,"threshold_uncertainty_score":0.9980617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072043914","doi":"10.1038/ng.419","title":"Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma","year":2009,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Follicular lymphoma; Chronic lymphocytic leukemia; Lymphoma; Biology; Follicular phase; Allele; Genetic association; Genome-wide association study; Leukemia; Genetics; Single-nucleotide polymorphism; Immunology; Gene; Genotype","authors":[{"name":"Christine F. Skibola","is_ca":false},{"name":"Paige M. Bracci","is_ca":false},{"name":"Eran Halperin","is_ca":false},{"name":"Lucía Conde","is_ca":false},{"name":"David W. Craig","is_ca":false},{"name":"Luz Agana","is_ca":false},{"name":"Kelly Iyadurai","is_ca":false},{"name":"Nikolaus Becker","is_ca":false},{"name":"Angela Brooks‐Wilson","is_ca":true},{"name":"John Curry","is_ca":false},{"name":"John J. Spinelli","is_ca":true},{"name":"Elizabeth A. Holly","is_ca":false},{"name":"Jacques Riby","is_ca":false},{"name":"Luoping Zhang","is_ca":false},{"name":"Alexandra Nieters","is_ca":false},{"name":"Martyn T. Smith","is_ca":false},{"name":"Kevin M. Brown","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01167607600136909,"gpt":0.2837860582958836,"spread":0.2721099822945145,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000332504,0.0003706716,0.0005516759,0.0001603735,0.0001541011,0.00004444668,0.0003519591,0.0007842272,0.0001492843],"category_scores_gemma":[0.0007930396,0.0002968596,0.0001400077,0.00087584,0.00009842141,0.00002864832,0.0001524898,0.0004710286,0.0001465351],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01360762,"about_ca_system_score_gemma":0.002770076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003105411,"about_ca_topic_score_gemma":0.0003693395,"domain_scores_codex":[0.9964756,0.0001063643,0.0003696165,0.0008273425,0.001338747,0.000882278],"domain_scores_gemma":[0.9973338,0.0001145536,0.0001266225,0.00124219,0.0005434949,0.0006393321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01101548,0.00758861,0.6132522,0.0008749351,0.003097033,0.01899906,0.003466101,0.004887798,0.07943644,0.0001850885,0.1397851,0.1174123],"study_design_scores_gemma":[0.0151984,0.001500341,0.9625134,0.0002437604,0.0002290761,0.0004268638,0.00004018101,0.002715681,0.009090995,0.0001299823,0.007470693,0.0004405996],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938484,0.002191445,0.0001157434,0.001005253,0.0001700177,0.001093776,0.00004784803,0.0001307598,0.001396777],"genre_scores_gemma":[0.9905846,0.00009570416,0.00358331,0.003273361,0.0003497792,0.00001694621,0.00005403896,0.00006153929,0.001980694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3492613,"threshold_uncertainty_score":0.9999484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281385697","doi":"10.1182/blood.2021015014","title":"Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Servier; BeiGene; Adaptive Biotechnologies; TG Therapeutics; Incyte; F. Hoffmann-La Roche; Amsterdam University Medical Centers; Gilead Sciences; Universiteit van Amsterdam; Leukemia and Lymphoma Society; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Amgen; Breast Cancer Research Foundation; Celgene; Pharmacyclics; Genentech; California Institute for Regenerative Medicine","keywords":"Rituximab; Medicine; Venetoclax; Bendamustine; Internal medicine; Regimen; Population; Progression-free survival; Oncology; Chemotherapy regimen; Gastroenterology; Chemotherapy; Surgery; Chronic lymphocytic leukemia; Leukemia; Lymphoma","authors":[{"name":"John F. Seymour","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"James D’Rozario","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"Nicole Lamanna","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Clemens Mellink","is_ca":false},{"name":"Brenda Chyla","is_ca":false},{"name":"Anesh Panchal","is_ca":false},{"name":"Tong Lu","is_ca":false},{"name":"Jenny Wu","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Marcus Lefebure","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"Arnon P. Kater","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01165059563415755,"gpt":0.260368235767024,"spread":0.2487176401328665,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003496589,0.0001508487,0.0003114985,0.0002283206,0.0001093329,0.00002607458,0.0001032757,0.00008100756,0.0006839983],"category_scores_gemma":[0.0001122414,0.0001461158,0.00005073591,0.0003124973,0.00005011896,0.00009187213,0.0002583512,0.0004596076,0.00003453734],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005076632,"about_ca_system_score_gemma":0.001984617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004923367,"about_ca_topic_score_gemma":0.0001489959,"domain_scores_codex":[0.9983429,0.0001073782,0.0003192991,0.0003589601,0.0004763233,0.0003950877],"domain_scores_gemma":[0.9993273,0.0001003257,0.0000590136,0.0003654294,0.00003147225,0.0001164438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01055033,0.0185289,0.7814404,0.002390367,0.001984256,0.01840313,0.01079927,0.0008401895,0.1312255,0.0004906111,0.003621469,0.01972558],"study_design_scores_gemma":[0.4649101,0.003381255,0.4127929,0.0003735021,0.0007562676,0.00281589,0.002687863,0.01582547,0.06270841,0.0005987551,0.03154936,0.001600279],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971219,0.001020082,0.000003157488,0.0002081697,0.00009506032,0.0004824678,0.00001493806,0.00006592569,0.0009882393],"genre_scores_gemma":[0.9971553,0.00003854093,0.0001580149,0.0002000986,0.00005862866,0.0002087168,0.00003796991,0.00003618737,0.002106526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4543597,"threshold_uncertainty_score":0.9987427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985094563","doi":"10.1084/jem.191.5.781","title":"A Dual Role for Src Homology 2 Domain–Containing Inositol-5-Phosphatase (Ship) in Immunity","year":2000,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; Medical Research Council Canada","keywords":"Biology; B cell; Cell biology; Antigen; Receptor; Molecular biology; Immunology; Antibody; Biochemistry","authors":[{"name":"Cheryl D. Helgason","is_ca":true},{"name":"Christian P. Kalberer","is_ca":true},{"name":"Jacqueline E. Damen","is_ca":true},{"name":"Suzanne M. Chappel","is_ca":true},{"name":"Nicolas Pineault","is_ca":true},{"name":"Gerald Krystal","is_ca":true},{"name":"R. Keith Humphries","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02534752383577781,"gpt":0.3498490093042118,"spread":0.3245014854684339,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002009308,0.0002062272,0.0006573593,0.0002083733,0.000131735,0.000007921712,0.0003204169,0.0001055936,0.001395405],"category_scores_gemma":[0.0002499907,0.0001229268,0.0001115144,0.0002667019,0.0005094251,0.0001252562,0.00006831425,0.0005861982,0.00001718986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00347862,"about_ca_system_score_gemma":0.001250843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001100356,"about_ca_topic_score_gemma":0.00002842598,"domain_scores_codex":[0.9977251,0.0002520145,0.0008054014,0.0001436971,0.0005894122,0.000484371],"domain_scores_gemma":[0.9983455,0.0006942386,0.000214968,0.0003738242,0.0001140836,0.0002574142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1228513,0.004124586,0.001968486,0.0003055132,0.001244621,0.006547968,0.1140508,0.0001470484,0.6801135,0.003075052,0.02116234,0.04440882],"study_design_scores_gemma":[0.2742801,0.04438023,0.004077168,0.002985629,0.0006222344,0.04816801,0.10182,0.00271318,0.4787943,0.002916658,0.03850837,0.0007341396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9720783,0.02226186,0.00002493871,0.002748903,0.0002078617,0.0005741192,0.0000043119,0.00001059741,0.00208907],"genre_scores_gemma":[0.9971329,0.0003344961,0.0005020515,0.0009360727,0.0007543431,0.0000216135,0.00001275821,0.00003022962,0.0002755225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2013192,"threshold_uncertainty_score":0.9995174,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117585236","doi":"10.1371/journal.pone.0087645","title":"Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis Risk Gene","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; McGill University and Génome Québec Innovation Centre","funders":"National Institute for Health and Care Research; National Institute of General Medical Sciences; Qatar National Research Fund; Japan Society for the Promotion of Science; U.S. Public Health Service; Japan Science and Technology Agency; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Versus Arthritis; Fonds National de la Recherche Luxembourg; Canadian Institutes of Health Research; Burroughs Wellcome Fund","keywords":"Genetics; Population; Allele frequency; Pedigree chart; Allele; Candidate gene; Biology; Locus (genetics); Medicine; Gene","authors":[{"name":"Yukinori Okada","is_ca":false},{"name":"Dorothée Diogo","is_ca":false},{"name":"Jeffrey D. Greenberg","is_ca":false},{"name":"Faten Mouassess","is_ca":false},{"name":"Walid Al Achkar","is_ca":false},{"name":"Robert S. Fulton","is_ca":false},{"name":"Joshua C. Denny","is_ca":false},{"name":"Namrata Gupta","is_ca":false},{"name":"Daniel B. Mirel","is_ca":false},{"name":"Stacy Gabriel","is_ca":false},{"name":"Gang Li","is_ca":false},{"name":"Joel M. Kremer","is_ca":false},{"name":"Dimitrios A. Pappas","is_ca":false},{"name":"Robert J. Carroll","is_ca":false},{"name":"Anne E. Eyler","is_ca":false},{"name":"Gosia Trynka","is_ca":false},{"name":"Eli A. Stahl","is_ca":false},{"name":"Jing Cui","is_ca":false},{"name":"Richa Saxena","is_ca":false},{"name":"Marieke J. H. Coenen","is_ca":false},{"name":"Henk‐Jan Guchelaar","is_ca":false},{"name":"T. Huizinga","is_ca":false},{"name":"Philippe Dieudé","is_ca":false},{"name":"Xavier Mariette","is_ca":false},{"name":"Anne Barton","is_ca":false},{"name":"Helena Canhão","is_ca":false},{"name":"João Eurico Fonseca","is_ca":false},{"name":"Niek de Vries","is_ca":false},{"name":"Paul P. Tak","is_ca":false},{"name":"Larry W. Moreland","is_ca":false},{"name":"S. Louis Bridges","is_ca":false},{"name":"Corinne Miceli‐Richard","is_ca":false},{"name":"Hyon K. Choi","is_ca":false},{"name":"Pilar Galán","is_ca":false},{"name":"Mark Lathrop","is_ca":true},{"name":"Towfique Raj","is_ca":false},{"name":"Philip L. De Jager","is_ca":false},{"name":"Soumya Raychaudhuri","is_ca":false},{"name":"Jane Worthington","is_ca":false},{"name":"Leonid Padyukov","is_ca":false},{"name":"Lars Klareskog","is_ca":false},{"name":"Katherine Siminovitch","is_ca":true},{"name":"Peter K. Gregersen","is_ca":false},{"name":"Elaine R. Mardis","is_ca":false},{"name":"Thurayya Arayssi","is_ca":false},{"name":"Layla Kazkaz","is_ca":false},{"name":"Robert M. Plenge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09977477278799306,"gpt":0.3187639287372409,"spread":0.2189891559492478,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004006493,0.0002256526,0.0006052145,0.0001196843,0.00008891766,0.00008554097,0.0008309961,0.0001233782,0.0002048384],"category_scores_gemma":[0.001462559,0.0001951841,0.0000218248,0.0001956123,0.0002012377,0.0004262661,0.000442734,0.0002471055,0.00009282674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008284312,"about_ca_system_score_gemma":0.001480084,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2454349,"about_ca_topic_score_gemma":0.02573216,"domain_scores_codex":[0.9969624,0.0002422359,0.0005652356,0.0008847562,0.001043033,0.0003023168],"domain_scores_gemma":[0.9952503,0.0002977287,0.0003109091,0.003675893,0.0002537589,0.000211436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002541116,0.001728989,0.05201622,0.0002297795,0.001943929,0.0003225609,0.001815506,0.00007802198,0.9200172,0.00001792686,0.0009971323,0.0182916],"study_design_scores_gemma":[0.0192365,0.0009737245,0.1062512,0.003248079,0.000819426,0.0001078395,0.0004771801,0.7978009,0.06963275,0.0008561983,0.00006985146,0.0005263466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900956,0.001794387,0.002409927,0.00008175049,0.00004467212,0.0006528217,0.004787752,0.0000830785,0.00005004371],"genre_scores_gemma":[0.9473855,0.002458057,0.02014099,0.00008707462,0.0001727077,0.00002311527,0.02962853,0.00005018481,0.00005383639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8503845,"threshold_uncertainty_score":0.9920457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2043831614","doi":"10.1182/blood-2008-09-177329","title":"Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"National Cancer Institute","keywords":"Medicine; Fludarabine; Rituximab; Waldenstrom macroglobulinemia; Internal medicine; Macroglobulinemia; Neutropenia; Gastroenterology; Surgery; Lymphoma; Chemotherapy; Cyclophosphamide; Multiple myeloma","authors":[{"name":"Steven P. Treon","is_ca":false},{"name":"Andrew R. Branagan","is_ca":false},{"name":"Leukothea Ioakimidis","is_ca":false},{"name":"Jacob D. Soumerai","is_ca":false},{"name":"Christopher J. Patterson","is_ca":false},{"name":"Barry Turnbull","is_ca":false},{"name":"Parveen Wasi","is_ca":true},{"name":"Christos Emmanouilides","is_ca":false},{"name":"Stanley R. Frankel","is_ca":false},{"name":"Andrew Lister","is_ca":false},{"name":"Pierre Morel","is_ca":false},{"name":"Jeffrey Matous","is_ca":false},{"name":"Stephanie A. Gregory","is_ca":false},{"name":"Eva Kimby","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02937707616211306,"gpt":0.3144924683044922,"spread":0.2851153921423791,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001452201,0.0001833972,0.0004536237,0.0001929903,0.0000553323,0.0000142066,0.000126843,0.0001112225,0.0001066218],"category_scores_gemma":[0.0002420731,0.0001533334,0.00006083578,0.000294319,0.0001234633,0.00005175035,0.0001667586,0.0002257952,0.0002280271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001150276,"about_ca_system_score_gemma":0.001298502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000312665,"about_ca_topic_score_gemma":0.0001587441,"domain_scores_codex":[0.9983882,0.00002589588,0.0003017132,0.0003834288,0.0004189388,0.0004817773],"domain_scores_gemma":[0.9990694,0.00008784674,0.00002723401,0.0004251737,0.00006336636,0.0003270032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002776735,0.003147153,0.9765149,0.0002474994,0.0001107098,0.01115997,0.0005762586,0.000001407591,0.002194821,0.00003210556,0.0007896823,0.004947821],"study_design_scores_gemma":[0.1224613,0.0002748585,0.8635204,0.0001614559,0.00007116188,0.005770807,0.00002186772,0.00009808323,0.007071713,0.00001489555,0.0003079583,0.0002255467],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964069,0.0006811259,0.00001099178,0.001173565,0.00005313061,0.0005223626,0.000007378118,0.00006156311,0.001082969],"genre_scores_gemma":[0.9957027,0.0001925143,0.001057037,0.0005599287,0.0001151625,0.00003445187,0.00001311081,0.00003011962,0.002294903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1221836,"threshold_uncertainty_score":0.6252756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988367968","doi":"10.1182/blood-2012-02-408773","title":"A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; University of British Columbia; London Health Sciences Centre; Jewish General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Neutropenia; Internal medicine; Maintenance therapy; Tolerability; Regimen; Rituximab; Phases of clinical research; Population; CD20; Gastroenterology; Surgery; Lymphoma; Oncology; Clinical trial; Chemotherapy; Adverse effect","authors":[{"name":"Laurie H. Sehn","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"Douglas A. Stewart","is_ca":false},{"name":"Joy Mangel","is_ca":true},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Gregg Fine","is_ca":false},{"name":"Susan Frances-Lasserre","is_ca":false},{"name":"David Carlile","is_ca":false},{"name":"Michael Crump","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009608775374167903,"gpt":0.2575599199963363,"spread":0.2479511446221684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002319348,0.0001173158,0.000346523,0.0001358336,0.00001479362,0.000002903146,0.00008683192,0.00007193446,0.00001581541],"category_scores_gemma":[0.00009912693,0.00009773839,0.00003849101,0.0003890948,0.0000887179,0.0001133872,0.00004575719,0.0001480349,0.000005138799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001745045,"about_ca_system_score_gemma":0.0009865001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007157812,"about_ca_topic_score_gemma":0.000018815,"domain_scores_codex":[0.9985532,0.0000721504,0.0003184425,0.0001931394,0.0005357585,0.0003273334],"domain_scores_gemma":[0.999207,0.00006040446,0.0001616548,0.0003103655,0.0001657004,0.00009492869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01869983,0.2412132,0.5834898,0.0008985196,0.001095811,0.000251023,0.04071902,0.00001652082,0.1073544,0.00004162209,0.002625881,0.003594362],"study_design_scores_gemma":[0.6436188,0.01650538,0.1974216,0.0005866786,0.0004741305,0.00002504647,0.00415552,0.00003996773,0.1368298,0.000003825338,0.00006961555,0.0002696407],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983596,0.0001553854,0.000004725591,0.000005012667,0.00004547143,0.001071277,0.00002550051,0.00001097916,0.0003220671],"genre_scores_gemma":[0.9994683,0.000007115596,0.0001343491,0.00001009344,0.00002065666,0.00003912891,0.00002811361,0.00002333935,0.000268861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.624919,"threshold_uncertainty_score":0.4563231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308949853","doi":"10.1038/s41573-022-00582-5","title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cancer Research Society; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Michael Smith Health Research BC; National Cancer Institute; National Science Foundation","keywords":"Phosphoinositide 3-kinase; Kinase; Disease; Medicine; Biology; Cancer research; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; Internal medicine","authors":[{"name":"John E. Burke","is_ca":true},{"name":"Joanna Triscott","is_ca":false},{"name":"Brooke M. Emerling","is_ca":false},{"name":"Gerald Hammond","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03358830935975977,"gpt":0.3736598770361418,"spread":0.3400715676763821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002414972,0.001244241,0.005727476,0.0007454126,0.0001862315,0.0001684037,0.001000354,0.0006485445,0.001391407],"category_scores_gemma":[0.004073565,0.000913306,0.002574246,0.002175599,0.0001762938,0.0004610181,0.0009713273,0.005835122,0.0003385977],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02725889,"about_ca_system_score_gemma":0.02066706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002184527,"about_ca_topic_score_gemma":0.00003834851,"domain_scores_codex":[0.991957,0.001257138,0.002217587,0.001716018,0.001625882,0.001226347],"domain_scores_gemma":[0.995171,0.001385195,0.0008582677,0.001896068,0.00005894165,0.0006305478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001234242,0.0004311686,0.00002218011,0.1728276,0.0001954784,0.004369425,0.0001022512,0.000002059084,2.727495e-7,0.0003408463,0.06441926,0.7571661],"study_design_scores_gemma":[0.002045826,0.00003750883,0.000003672189,0.05798575,0.001594581,0.0002261932,0.00004425356,0.00001524085,0.000001150411,0.00005791592,0.9372263,0.0007616292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004703293,0.9900309,0.000001279603,0.0001328885,0.0009197943,0.005784293,0.0002958885,0.00008319603,0.002704771],"genre_scores_gemma":[0.00002253364,0.9869416,0.0001168528,0.0009450843,0.0009946779,0.001786909,0.003068383,0.0002611479,0.00586276],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.872807,"threshold_uncertainty_score":0.9995214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2290262197","doi":"10.1126/scitranslmed.aad7666","title":"A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies","year":2016,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"National Heart, Lung, and Blood Institute; NIHR Cambridge Biomedical Research Centre; NIHR BioResource; Vlaamse regering; Fonds Wetenschappelijk Onderzoek; Onderzoeksraad, KU Leuven; Imperial College London; British Heart Foundation; KU Leuven; National Institute for Health and Care Research; Medical Research Council; British Society for Haematology; NHS Blood and Transplant","keywords":"Myelofibrosis; Gain of function; Medicine; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Mutation; Function (biology); Platelet; Cancer research; Internal medicine; Bone marrow; Biology; Receptor; Genetics; Gene","authors":[{"name":"Ernest Turro","is_ca":false},{"name":"Daniel Greene","is_ca":false},{"name":"Anouck Wijgaerts","is_ca":false},{"name":"Chantal Thys","is_ca":false},{"name":"Claire Lentaigne","is_ca":false},{"name":"Tadbir K. Bariana","is_ca":false},{"name":"Sarah K. Westbury","is_ca":false},{"name":"Anne M. Kelly","is_ca":false},{"name":"Dominik Selleslag","is_ca":false},{"name":"Jonathan Stephens","is_ca":false},{"name":"Sofia Papadia","is_ca":false},{"name":"Ilenia Simeoni","is_ca":false},{"name":"Christopher J. Penkett","is_ca":false},{"name":"Sofie Ashford","is_ca":false},{"name":"Antony Attwood","is_ca":false},{"name":"Steve Austin","is_ca":false},{"name":"Tamam Bakchoul","is_ca":false},{"name":"Peter Collins","is_ca":true},{"name":"Sri V. V. Deevi","is_ca":false},{"name":"Rémi Favier","is_ca":false},{"name":"Myrto Kostadima","is_ca":false},{"name":"Michele P. Lambert","is_ca":false},{"name":"Mary Mathias","is_ca":false},{"name":"Carolyn M. Millar","is_ca":false},{"name":"Kathelijne Peerlinck","is_ca":false},{"name":"David J. Perry","is_ca":false},{"name":"Sol Schulman","is_ca":false},{"name":"Deborah Whitehorn","is_ca":false},{"name":"Christine Wittevrongel","is_ca":false},{"name":"Marc De Maeyer","is_ca":false},{"name":"Augusto Rendon","is_ca":false},{"name":"Keith Gomez","is_ca":false},{"name":"Wendy N. Erber","is_ca":false},{"name":"Andrew Mumford","is_ca":false},{"name":"Paquita Nurden","is_ca":false},{"name":"Kathleen Stirrups","is_ca":false},{"name":"John R. Bradley","is_ca":false},{"name":"F. Lucy Raymond","is_ca":false},{"name":"Michael Laffan","is_ca":false},{"name":"Chris Van Geet","is_ca":false},{"name":"Sylvia Richardson","is_ca":false},{"name":"Kathleen Freson","is_ca":false},{"name":"Willem H. Ouwehand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02917084554683468,"gpt":0.3120914435771577,"spread":0.282920598030323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001254825,0.0001576253,0.0003818506,0.0005750722,0.0001105457,0.000009761146,0.0001269568,0.00006382656,0.0001258491],"category_scores_gemma":[0.0006507154,0.00009685776,0.00003195793,0.001016174,0.002719352,0.0004723427,0.00003948748,0.0001105411,0.000006407054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001127433,"about_ca_system_score_gemma":0.002419701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000364744,"about_ca_topic_score_gemma":0.00009801819,"domain_scores_codex":[0.997672,0.00004093266,0.0004219173,0.0004484899,0.001050875,0.0003657785],"domain_scores_gemma":[0.9987958,0.0004299997,0.0001082447,0.0002136518,0.0002847299,0.0001675885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0009544973,0.00008923379,0.007127441,0.0001398465,0.00001261141,0.0001501718,0.00150153,0.00003370184,0.9713618,0.00518857,0.0001062919,0.01333433],"study_design_scores_gemma":[0.09376312,0.005143614,0.5987275,0.004837262,0.0003960803,0.001486176,0.003503993,0.008826548,0.2717081,0.009374013,0.001496979,0.0007365739],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860285,0.001295494,0.003038588,0.008032871,0.0002243652,0.000506,0.00001287365,0.00003267777,0.0008286602],"genre_scores_gemma":[0.9983829,0.000376155,0.0008211968,0.0001097893,0.0001129501,0.00001280766,0.0000101293,0.00001133258,0.0001627119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6996537,"threshold_uncertainty_score":0.9999947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129783860","doi":"10.1182/blood-2008-04-150854","title":"Thalidomide and rituximab in Waldenstrom macroglobulinemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Thalidomide; Medicine; Rituximab; Internal medicine; Gastroenterology; Waldenstrom macroglobulinemia; Macroglobulinemia; Population; Adverse effect; Immunology; Surgery; Multiple myeloma; Lymphoma","authors":[{"name":"Steven P. Treon","is_ca":false},{"name":"Jacob D. Soumerai","is_ca":false},{"name":"Andrew R. Branagan","is_ca":false},{"name":"Zachary R. Hunter","is_ca":false},{"name":"Christopher J. Patterson","is_ca":false},{"name":"Leukothea Ioakimidis","is_ca":false},{"name":"Frederick Briccetti","is_ca":false},{"name":"Mark Pasmantier","is_ca":false},{"name":"Harvey Zimbler","is_ca":false},{"name":"Robert B. Cooper","is_ca":false},{"name":"Maria Moore","is_ca":false},{"name":"John M. Hill","is_ca":false},{"name":"Alan E. Rauch","is_ca":false},{"name":"Lawrence Garbo","is_ca":false},{"name":"Luis Chu","is_ca":false},{"name":"Cynthia C. Chua","is_ca":false},{"name":"Stephen H. Nantel","is_ca":true},{"name":"David Lovett","is_ca":false},{"name":"Hans Boedeker","is_ca":false},{"name":"Henry Sonneborn","is_ca":false},{"name":"John R. Howard","is_ca":false},{"name":"P. Musto","is_ca":false},{"name":"Bryan Ciccarelli","is_ca":false},{"name":"Evdoxia Hatjiharissi","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0194764630623255,"gpt":0.2690334252907942,"spread":0.2495569622284687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001374335,0.00011318,0.0002771601,0.00009962233,0.00004400514,0.000008294868,0.0000729824,0.00009376474,0.00007454187],"category_scores_gemma":[0.0001499571,0.00009866021,0.00004057765,0.0001755252,0.0001591818,0.00004243476,0.00008339425,0.0002105602,0.0000983015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008372703,"about_ca_system_score_gemma":0.001543634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005887764,"about_ca_topic_score_gemma":0.00004978279,"domain_scores_codex":[0.9988837,0.0000269123,0.0002012451,0.000260805,0.0002868925,0.0003403931],"domain_scores_gemma":[0.9994227,0.0000794817,0.00002357282,0.0002755969,0.00003683117,0.000161763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.00424024,0.03511148,0.7006527,0.002258544,0.001017886,0.1392764,0.007577485,0.00001426183,0.06062526,0.00158211,0.02014215,0.02750157],"study_design_scores_gemma":[0.7486917,0.0006007464,0.1310764,0.0004524618,0.0002283187,0.05153644,0.0002696922,0.002530534,0.05693314,0.0003706645,0.006713654,0.0005962678],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933195,0.001277113,0.000004349281,0.0003746886,0.00002835952,0.0002472386,0.000004052867,0.00004256977,0.004702184],"genre_scores_gemma":[0.9968618,0.00044848,0.001286595,0.0001732108,0.0001334432,0.0000161677,0.000007986954,0.00001936239,0.001052975],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7444515,"threshold_uncertainty_score":0.4023246,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129141528","doi":"10.1016/j.ccell.2015.02.003","title":"Self-Enforcing Feedback Activation between BCL6 and Pre-B Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Cancer Research UK; Wellcome Trust; Howard Hughes Medical Institute","keywords":"breakpoint cluster region; Cancer research; Biology; BCL6; Tyrosine kinase; Signal transduction; Leukemia; Kinase; Receptor; Cell biology; Immunology; B cell; Genetics; Antibody","authors":[{"name":"Huimin Geng","is_ca":false},{"name":"Christian Hurtz","is_ca":false},{"name":"Kyle Lenz","is_ca":false},{"name":"Zhengshan Chen","is_ca":false},{"name":"Dirk Baumjohann","is_ca":false},{"name":"Sarah K. Thompson","is_ca":false},{"name":"Natalya A. Goloviznina","is_ca":false},{"name":"Wei‐Yi Chen","is_ca":false},{"name":"Jianya Huan","is_ca":false},{"name":"Dorian LaTocha","is_ca":false},{"name":"Erica Ballabio","is_ca":false},{"name":"Gang Xiao","is_ca":false},{"name":"Jae Woong Lee","is_ca":false},{"name":"Anne Deucher","is_ca":false},{"name":"Zhongxia Qi","is_ca":false},{"name":"Eugene Park","is_ca":false},{"name":"Chuanxin Huang","is_ca":false},{"name":"Rahul Nahar","is_ca":false},{"name":"Soo-Mi Kweon","is_ca":false},{"name":"Seyedmehdi Shojaee","is_ca":false},{"name":"Lai N. Chan","is_ca":false},{"name":"Jingwei Yu","is_ca":false},{"name":"Steven M. Kornblau","is_ca":false},{"name":"Janet J. Bijl","is_ca":true},{"name":"B. Hilda Ye","is_ca":false},{"name":"K. Mark Ansel","is_ca":false},{"name":"Elisabeth Paietta","is_ca":false},{"name":"Ari Melnick","is_ca":false},{"name":"Stephen P. Hunger","is_ca":false},{"name":"Peter Kurre","is_ca":false},{"name":"Jeffrey Tyner","is_ca":false},{"name":"Mignon L. Loh","is_ca":false},{"name":"Robert G. Roeder","is_ca":false},{"name":"Brian Druker","is_ca":false},{"name":"Jan A. Burger","is_ca":false},{"name":"Thomas A. Milne","is_ca":false},{"name":"Bill H. Chang","is_ca":false},{"name":"Markus Müschen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02639569403894095,"gpt":0.2885069859949592,"spread":0.2621112919560182,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003011076,0.0002408492,0.0004720174,0.00009125975,0.00006481313,0.00002901421,0.0001502617,0.0001696586,0.0001264195],"category_scores_gemma":[0.0000975992,0.0002118654,0.00007237866,0.000307561,0.0001112912,0.0001868089,0.000129621,0.0001835553,0.00003083267],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01480784,"about_ca_system_score_gemma":0.009157417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002787292,"about_ca_topic_score_gemma":0.00002758451,"domain_scores_codex":[0.9981802,0.0000529245,0.0004084431,0.0004008306,0.0005258074,0.0004317746],"domain_scores_gemma":[0.9984481,0.0002897379,0.0002324874,0.0003349195,0.0003246703,0.0003700954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007959591,0.0006392937,0.1601167,0.01740318,0.001748515,0.0001185343,0.02091548,0.002015475,0.7547245,0.0001013639,0.01866264,0.01559477],"study_design_scores_gemma":[0.0275674,0.0008720286,0.004510634,0.0008168215,0.0009468207,0.00002655717,0.0005675424,0.01465582,0.9445823,0.00007056808,0.00485892,0.0005245667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930606,0.001208753,0.0005440058,0.00005456896,0.0001438827,0.0005265103,0.00003441244,0.0000769958,0.004350197],"genre_scores_gemma":[0.9958891,0.0003015177,0.001534303,0.00004457887,0.0004330651,0.00004308794,0.00006617878,0.00005740873,0.001630792],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1898578,"threshold_uncertainty_score":0.9964597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158196950","doi":"10.3324/haematol.13151","title":"Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphocytosis; Dasatinib; Natural killer cell; Lymphocyte; Immunology; CD16; CD3; Biology; Medicine; Cytotoxicity; Myeloid leukemia; CD8; Imatinib; Immune system","authors":[{"name":"Dong H. Kim","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Hong Chang","is_ca":true},{"name":"Robert Sutherland","is_ca":true},{"name":"Chang Wook Jung","is_ca":false},{"name":"H.-J. Kim","is_ca":false},{"name":"J.-J. Lee","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03405269464848501,"gpt":0.2943099288139732,"spread":0.2602572341654882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004655925,0.0007698711,0.001592308,0.000262602,0.0007365209,0.00005596629,0.0005343187,0.0005921387,0.0006261076],"category_scores_gemma":[0.0007681739,0.0004646255,0.0004686764,0.0008973517,0.0006934403,0.000232421,0.000181667,0.0007945881,0.00009790689],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.009295838,"about_ca_system_score_gemma":0.006583428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001340699,"about_ca_topic_score_gemma":0.00005703458,"domain_scores_codex":[0.9950731,0.0002367295,0.0007829298,0.00112472,0.001168439,0.001614077],"domain_scores_gemma":[0.9965366,0.001218257,0.0003916636,0.0008403934,0.0006015996,0.0004114521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1849427,0.01796211,0.02181081,0.004516006,0.01211153,0.1187384,0.02589686,0.0003265882,0.05232881,0.004270498,0.5543073,0.002788441],"study_design_scores_gemma":[0.5276347,0.01805539,0.05062881,0.002859779,0.001262606,0.03861934,0.001917411,0.08099233,0.223101,0.0002324754,0.04879929,0.005896872],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890337,0.003939864,0.0001296541,0.00134136,0.0006929503,0.003335123,0.00008975458,0.0004802144,0.0009574058],"genre_scores_gemma":[0.9868779,0.001028567,0.001396657,0.002546973,0.0002590913,0.0004409601,0.0008584897,0.0001462524,0.006445088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.505508,"threshold_uncertainty_score":0.9997805,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2787624638","doi":"10.1182/blood-2017-06-792267","title":"Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Chronic lymphocytic leukemia; Tumor microenvironment; Stromal cell; Cancer research; Immune checkpoint; Immune system; Blockade; Ibrutinib; Leukemia; Medicine; Immunology; Biology; Immunotherapy; Receptor; Internal medicine","authors":[{"name":"Marina Wierz","is_ca":false},{"name":"Sandrine Pierson","is_ca":false},{"name":"Léa Guyonnet","is_ca":true},{"name":"Elodie Viry","is_ca":false},{"name":"Audrey Lequeux","is_ca":false},{"name":"Anaïs Oudin","is_ca":false},{"name":"Simone P. Niclou","is_ca":false},{"name":"Markus Ollert","is_ca":true},{"name":"Guy Berchem","is_ca":false},{"name":"Bassam Janji","is_ca":false},{"name":"Coralie L. Guérin","is_ca":true},{"name":"Jérôme Paggetti","is_ca":false},{"name":"Etienne Moussay","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02813684716392201,"gpt":0.2685611499825817,"spread":0.2404243028186597,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009036305,0.001045644,0.002248563,0.001017449,0.00009783131,0.00004252448,0.0008363847,0.001299173,0.0003700799],"category_scores_gemma":[0.0004399254,0.0009718954,0.0004703063,0.0007541831,0.0005594564,0.00009955544,0.0006850201,0.002389229,0.0004437878],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1315581,"about_ca_system_score_gemma":0.1750272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001378075,"about_ca_topic_score_gemma":0.0001674121,"domain_scores_codex":[0.9921099,0.0001396667,0.002246385,0.001401804,0.002159236,0.001942987],"domain_scores_gemma":[0.996393,0.0002486458,0.0006609708,0.00193175,0.0004532604,0.0003124294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004684912,0.007991155,0.0002706209,0.07916726,0.01178161,0.09905479,0.00886328,0.00664479,0.2733931,0.00004535645,0.5013321,0.006771022],"study_design_scores_gemma":[0.1559968,0.001501058,0.0002215978,0.008384299,0.00135672,0.006105188,0.00004673432,0.1202908,0.6269001,0.00008942336,0.07699309,0.002114157],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786193,0.004365695,0.00003714615,0.01091448,0.0003450532,0.002467913,0.0000672729,0.0002112432,0.002971854],"genre_scores_gemma":[0.856039,0.001211976,0.0105903,0.0602504,0.0176881,0.001764862,0.002097949,0.001461023,0.0488964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.424339,"threshold_uncertainty_score":0.9999974,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}